Join Now

NCIA Members Making Their Mark at MJBizCon 2026

From the Expo floor to the conference stage to the events bringing the industry together, NCIA members are showing up across Las Vegas.

Every year, MJBizCon brings the cannabis industry together to build relationships, share ideas, do business, and help shape what comes next. In 2026, NCIA members will be part of that activity across the Expo floor, the conference program, and events happening throughout Las Vegas.

Our member community represents businesses and professionals working across nearly every corner of the cannabis industry. At MJBizCon, that expertise will be on display through product innovations, industry education, policy conversations, business services, and opportunities to connect.

We’ve pulled together this guide to make it easier to find NCIA members, catch their sessions, visit their booths, and support the organizations helping move the industry forward.

Whether you’re looking for a familiar face on the show floor, want to hear from a member expert, or are planning your week around industry gatherings, here’s where you can find NCIA members during MJBizCon 2026.

Find NCIA members on the Expo floor

Nineteen NCIA member companies are represented in the official MJBizCon 2026 exhibitor directory, reflecting the breadth of expertise, innovation, and industry solutions across our membership. From established operators to specialized service providers, these companies are helping shape the business, technology, and infrastructure driving the cannabis industry forward.

Look for these members at their booths:

NCIA member Booth
Abstrax Tech 20526
Accounting Buds 23525
Amoretti 23207
Bankcard International Group 25922
DaySavers 24617
Element Air by RGF Environmental Group 20529
Emerald Intel 26811
Hanwha Vision 26417
Linde Gas & Equipment 19433
O2VAPE 22318
Paragon Payroll 26522
Prairie Island CBH Inc. 23040
PreRoll-Er 22725
PROTEUS Business Solutions, Inc. 26721
Purpl Scientific Inc. 21028
Sage Software, Inc. 26917
SWEED POS 25617
Treeform Packaging Solutions LLC 24307
WECO 26122

From packaging and manufacturing to payment solutions, environmental systems, analytics, software, and more, these exhibitors reflect the range of businesses and expertise that make up NCIA’s membership.

Member spotlight: Abstrax Tech

Booth #20526

NCIA member Abstrax Tech is bringing an interactive experience to the Expo floor, with two cannabis-inspired craft sodas on tap: Gelato Apple Soda and Yuzu Gelonade Lemonade. Visitors can also sample terpene-infused gummies in three flavors, explore strain and flavor profiles at aroma stations, check out a peer-reviewed research wall, and pick up free samples and limited-edition merchandise.

Abstrax will also be represented at the 2026 Emjays International Cannabis Awards, with nominations for Business Services of the Year for training and education through Abstrax Academy on Seed Talent, and Cultivation (Non-Tech) Company of the Year for Abstrax Terpenes.

For booth locations and the full floor map, visit the official MJBizCon exhibitor directory and floor map.

Hear from NCIA members on the conference program

NCIA members are contributing to the conversations shaping the industry’s business, policy, science, and operational priorities. The 2026 program features member representatives across sessions, panels, meetups, and other conference programming.

Here are some opportunities to hear directly from NCIA member leaders:

Tuesday, December 1

  • NCIA at Associations Day | 2–5 p.m. | Las Vegas Convention Center, Central Hall
    NCIA will be on site for MJBizCon’s seventh annual Associations Day, joining more than 30 cannabis trade organizations and advocacy groups for an afternoon of networking, policy discussion, and industry collaboration. NCIA Chief Operating Officer Brooke Gilbert will be hosting the association’s table alongside a rotating group of NCIA Board of Directors members and Regional Ambassadors, giving attendees an opportunity to meet association leadership, learn more about NCIA’s work, and connect with the people helping move the industry forward. Associations Day brings together organizations working on the policy, market access, and business challenges shaping the cannabis industry.
  • International State of the Union | 4:15 p.m.
    Jamie Pearson, President and Founder of New Holland Group, joins a discussion of international cannabis markets and opportunities at The Industrial Event Space.
  • State of the Industry — Rescheduling | 4:30 p.m.
    Eric Berlin, Partner and Leader of the Cannabis Group at Dentons US LLP, joins the conversation on cannabis rescheduling at The Industrial Event Space.

Wednesday, December 2

  • From Data to Demand: Modern Cannabis Marketing | 11 a.m.–11:45 a.m.
    Ed Keating, Chief Economist at Emerald Intel, joins the Innovation Stage discussion on how data informs modern cannabis marketing.
  • Jews in Weed Meetup | 12 p.m.–1 p.m.
    Jordan Isenstadt, SVP of Cannabis & Psychedelics at Marino PR, is featured in this gathering at The Hub.
  • Solving for Schedule III: What Rescheduling Means for Operators | 11 a.m.–11:50 a.m.
    Morgan Fox, Political Director at NORML, represents in this discussion in Room N109.
  • HCN Live CannaPitch at MJBizCon 2026 | 2 p.m.
    Mark Collins, Producer and President of Highly Capitalized Network, takes part in the program at the Innovation Stage.
  • Ohio & Michigan State Takeovers | 3 p.m.
    Emilie Ramach of BeneLeaves Limited participates in this state-focused gathering at The Grow Hub.

Thursday, December 3

  • Crossing Borders: Cannabis Global Expansion and the New International Policy Map | 10:50 a.m.–11:30 a.m.
    Jamie Pearson of New Holland Group and Willy Vlasic, CEO of Vlasic Bioscience, join this discussion in Room N114 on international expansion and the evolving policy landscape.
  • Building a Safety Standard for Cannabis Vape Products | 11:40 a.m.–12:20 p.m.
    Jennifer Guild, Chief Science Officer at Abstrax Tech, and TJ Martin, VP of Regulatory & Quality at VapeSAFER, join this session in Room N114 focused on a science-based approach to product safety.
  • From Hardware to Packaging: Building a More Sustainable Cannabis Ecosystem | 2 p.m.–2:40 p.m.
    Douglas Fischer, President and Director of VapeSAFER, joins the discussion in Room N111.

Friday, December 4

  • Lounge Ready: Mastering Cannabis Hospitality | 10 a.m.–11 a.m.
    Dale Sky Jones, Executive Chancellor and CEO of Oaksterdam University, leads this moderator-led roundtable in Room N110.

Be sure to check the official MJBizCon conference schedule for the latest session information and any program updates.

Connect with NCIA members during MJBizCon week

The conversations don’t stop when the Expo closes. NCIA members are hosting, supporting, and participating in gatherings throughout the week, creating additional opportunities to connect with colleagues, clients, and industry leaders.

Here are member-connected events and gatherings identified for MJBizCon week. All times below are Pacific Time. Check each event link for current registration details, access requirements, and availability.

Tuesday, December 1

Cannabis Hospitality Leadership Summit — Luna Stower LLC
11 a.m.–5 p.m. | Historic Fifth Street School

Luna Stower of Luna Stower Strategies LLC Consulting Agency is speaking at the Cannabis Hospitality Leadership Summit. The summit brings together hospitality operators, budtenders, brands, and industry leaders for a day of discussion and collaborative mastermind sessions focused on the future of cannabis hospitality. 

Event information and registration

The Grasslands Supperclub — Grasslands
6–10 p.m. | Private location shared with approved guests

NCIA member Grasslands brings together a curated group of cannabis and hemp executives, investors, and journalists for an evening of networking, conversation, and dinner. Attendance is subject to application and approval.

Learn more and apply

INCBA Solicitors Soirée — International Cannabis Bar Association
7–10 p.m. | Location shared privately with registrants

The International Cannabis Bar Association hosts its MJBizCon-week afterparty for the Cannabis Law Sessions. Admission is complimentary for Cannabis Law Sessions attendees and INCBA members; other guests can register for a fee.

Event details and registration

Smoke & Magic! 2026 — Paragon Payroll / FlowerHire
7–10 p.m. | Las Vegas Arts District

Paragon Payroll and Sweed POS are co-presenting sponsors of FlowerHire’s Smoke & Magic, an invite-only industry gathering in Las Vegas’s Arts District. Their sponsorship puts both NCIA members alongside FlowerHire in bringing together cannabis industry professionals for an evening of networking and connection. Please note that cannabis consumption is not permitted at the event.

Event information

Light Up Las Vegas — PayRio / Party. Play. Purify.
8 p.m.–midnight | Fremont Country Club

PayRio is supporting PufCreativ’s “Party. Play. Purify.” event series, bringing the industry together through music, culture, networking, and community experiences. Light Up Las Vegas kicks off the series on Tuesday night.

Tickets and event details

Wednesday, December 2

Golden Paddle Showdown — PayRio / Party. Play. Purify.
1–5 p.m. | Chicken N Pickle, Henderson

The “Party. Play. Purify.” series continues with an afternoon of pickleball and industry networking. Spectator registration is available, and team registration is offered for players.

Tickets and event details

The Grasslands Party — Grasslands
Evening | Invitation-only; location shared with approved guests

NCIA member Grasslands brings its annual gathering of cannabis and psychedelics executives, tastemakers, and journalists back to Las Vegas. Attendance is curated, with invitations and applications managed by Grasslands.

Learn more and apply

Elevated Minds Social Hour — Cannabis Creative Group
4–8 p.m. | Dazed! Consumption Lounge at Planet 13

Hosted by Cannabis Creative Group, Elevated Minds brings the community together for an evening of networking at Dazed! Consumption Lounge.

Event information

M4MM Presents: MJBizCon After Dark — Minorities for Medical Marijuana (M4MM)
8 p.m. | The Foreign Exchange / Kinfolk Speakeasy Lounge

M4MM hosts an evening of music, food, and intentional industry connections in downtown Las Vegas. Admission is complimentary, with a suggested donation benefiting the Las Vegas Sickle Cell Foundation.

Event details

Thursday, December 3

Jews in Weed Bagel Bash – Marino.
8 a.m.– 11 a.m. | Planet 13

The LEGENDARY Jews in Weed Bagel Bash is coming back to Las Vegas for MJBiz Con on Thursday, December 3rd. Whether you work in cannabis, hemp, psychedelics, media, law, finance, retail or advocacy—or you’re an ally who knows a good bagel when you see one—you’re welcome here.

Ticket and event details

High Spirits Morning Mixer — Vertosa
10 a.m.–noon | ARIA Resort & Casino

The High Spirits Morning Mixer brings cannabis professionals together for a morning of conversation and connection. The event is powered by Ordo Verde, Vertosa, and Wolf Meyer. Registration is free, but space is limited and host approval is required. The exact meeting location is shared with approved attendees.

Request an RSVP

Breathe & Heal: Sound Healing Brunch — PayRio / Party. Play. Purify.
Noon–4 p.m. | Shine Alternative Fitness

The Party. Play. Purify. series closes with a wellness-focused gathering featuring breathwork, a guided sound bath, movement, and brunch.

Tickets and event details

Elevate with Sage + Wherefour
6–9 p.m. | Bar Zazu, Resorts World Las Vegas

NCIA members Sage and Wherefour are bringing cannabis finance and operations leaders together for a private MJBizCon happy hour at Bar Zazu. Guests can enjoy complimentary drinks, food throughout the evening, networking with industry peers, and an exclusive giveaway. The gathering offers an opportunity to connect with the Sage and Wherefour teams and exchange ideas about the evolving financial and operational needs of the cannabis industry.

Invite-only event. Open to MJBizCon attendees with a conference badge.

Event details and registration

The 7th Annual MJBizCon DICE Mixer — Minorities for Medical Marijuana (M4MM)
8 p.m. | Private mansion; location shared with registrants

M4MM brings back its annual Diversity in Cannabis Experience (DICE) Mixer for an evening of networking, food, music, and connection. This year’s event is powered by Buds & Bubbly and features an all-black dress code.

Event details and tickets

Friday, December 4

Party for the People — NECANN
2–6 p.m. | Las Vegas; venue shared with ticket holders

NECANN and The Weedaker Group host an afternoon gathering with music, food, drinks, brand activations, and opportunities to connect with the community. The event is 21+ and requires registration.

Tickets and event details

Make time to connect with your NCIA community

MJBizCon is an important week for the cannabis industry, but the relationships built here can carry well beyond the conference. Take time to visit NCIA members on the Expo floor, attend their sessions, support their events, and make new connections.

The organizations highlighted here represent just a portion of the broader NCIA community. Across the industry, our members are building businesses, sharing expertise, creating opportunities, and helping shape the future of cannabis.

We’re proud to see them showing up across MJBizCon week, and we encourage attendees to seek them out.

Are you an NCIA member participating in MJBizCon 2026 and don’t see your organization listed? Let the NCIA team know about your booth, speaking engagement, sponsorship, or event so we can help get the word out.

Learn more about the benefits of NCIA membership and how to get involved at thecannabisindustry.org.

We look forward to seeing you in Las Vegas!

Join an NCIA Committee in 2027: Connect, Collaborate & Contribute

2027 Committee Applications Are Now Open!

The cannabis industry is evolving, and the conversations, connections, and collaboration that move it forward must evolve with it.

The National Cannabis Industry Association (NCIA) is opening applications for its 2027 committee year, inviting members from across the cannabis industry to share their expertise, connect with peers, and help develop practical solutions to the challenges facing cannabis businesses.

This year also marks an important new chapter for NCIA’s committee program. In response to member feedback and the changing needs of the industry, NCIA is restructuring its committees to create more focused, collaborative, and business-oriented opportunities for engagement.

The redesigned program will bring together cannabis operators, suppliers, service providers, technology companies, and subject-matter experts around shared business priorities, with an increased emphasis on meaningful participation and tangible resources that benefit the broader NCIA membership.

Whether you’re an established industry leader, an emerging business, or a professional supporting the cannabis industry, there is an opportunity to contribute.

A New Approach to Industry Collaboration

Over the years, NCIA’s committees have provided a platform for members to exchange ideas, share expertise, develop educational programming, and engage with important issues affecting the cannabis industry.

As the industry matures, however, member needs and business priorities continue to change. Feedback from members has highlighted the importance of creating more opportunities for cross-sector collaboration, making committee participation more productive, and ensuring that committee discussions translate into meaningful value for members.

The 2027 restructuring is designed to address those priorities.

Moving from the previous collection of 13 committees to seven consolidated, business-focused committees, the new structure will create more opportunities for professionals with complementary expertise to work together.

Rather than organizing participation exclusively around individual disciplines or professional specialties, the redesigned committees will bring together operators and the businesses that support them to address shared operational, commercial, financial, and organizational challenges.

The goal is straightforward: create stronger connections, encourage more active participation, and turn industry expertise into practical educational resources that cannabis businesses can put to use.

Meet the Seven 2027 NCIA Committees

The redesigned committee structure features seven areas of focus, each bringing together a diverse mix of cannabis businesses and supporting professionals.

1. Banking & Financial Services

Bringing together cannabis businesses and financial professionals to address the evolving financial landscape, including banking access, payments, lending, cash management, financial compliance, accounting, taxation, and the impact of Section 280E.

  • Ideal for banks, credit unions, financial institutions, payment providers, lenders, fintech companies, accounting and tax professionals, and cannabis businesses navigating the industry’s financial challenges.

2. Retail & Consumer Business

Exploring the operational and commercial challenges of serving cannabis consumers, including retail operations, customer experience, sales, delivery, retail technology, and changing consumer expectations.

  • Ideal for dispensary owners and operators, delivery businesses, consumer-facing brands, point-of-sale and e-commerce providers, loyalty platforms, and professionals supporting retail operations.

3. Cultivation & Facilities

Addressing cultivation performance, facility planning and design, production environments, resource efficiency, and the technologies and services that support cannabis facilities.

  • Ideal for cultivators, facility owners and operators, architects, engineers, designers, construction professionals, and specialists in energy, water, environmental management, and resource efficiency.

4. Manufacturing, Product & Quality

Advancing product development, manufacturing operations, quality systems, production efficiency, packaging, testing, and product innovation.

  • Ideal for manufacturers, processors, extraction businesses, cannabis brands, packaging companies, testing laboratories, researchers, scientific and technical professionals, and manufacturing technology providers.

5. Business Operations, Legal & Risk

Helping cannabis businesses navigate operational complexity, legal and regulatory compliance, risk management, insurance, technology, logistics, and business continuity.

  • Ideal for cannabis business owners and operations leaders, attorneys, insurance and risk management professionals, compliance consultants, logistics providers, and companies supporting core business operations.

6. Marketing, Sales & Business Growth

Exploring how cannabis businesses can strengthen their brands, reach customers, build relationships, improve marketing effectiveness, and develop sustainable sales and business growth strategies.

  • Ideal for cannabis brands and operators, marketing and sales leaders, advertising and public relations agencies, media companies, marketing technology providers, and business development professionals.

7. People, Talent & Workplace

Addressing the organizational and workforce challenges facing cannabis businesses, including talent acquisition, employee development, leadership, workplace policies, management practices, and workforce training.

  • Ideal for human resources professionals, business owners and managers, recruiters, staffing professionals, workforce development organizations, and employment and professional development service providers.

Each committee is designed to welcome a mix of operators and supporting businesses whose experience and expertise can contribute to its focus.

From Conversation to Meaningful Outcomes

The redesigned committee program places a greater emphasis on active participation, shared priorities, and tangible outcomes.

Committees will meet monthly, providing a consistent opportunity for members to build relationships, exchange insights, identify common challenges, and move collaborative projects forward.

Each committee will establish at least two to three annual priorities and focus on a manageable number of projects that reflect real business needs and create value for NCIA members.

Potential projects and deliverables include:

  • Educational webinars and presentations: Sharing specialized knowledge and practical insights with the broader industry.
  • Articles, guides, and business resources: Developing actionable information that members can apply within their organizations.
  • Peer roundtables and discussions: Creating opportunities for members to exchange experiences and explore shared challenges.
  • Case studies and industry examples: Highlighting real-world approaches, lessons learned, and successful business practices.
  • Short-form educational content: Producing recorded videos and other accessible resources that make member expertise available to a wider audience.
  • Research and information gathering: Identifying emerging trends and common business challenges to inform future educational initiatives.

Committee members will help identify priorities, contribute subject-matter expertise, and take ownership of projects that align with their experience and interests.

NCIA staff will work alongside committee leadership to coordinate activities, provide organizational support, align projects with broader association priorities, and help share completed resources with the membership.

The objective is to move beyond meetings for the sake of meetings and build a more productive environment where members can make connections, contribute their knowledge, and see the results of their involvement.

Who Can Participate?

Committee participation is an exclusive benefit of NCIA membership. Applicants must represent an organization with an active, paid NCIA membership in good standing.

The number of guaranteed committee seats available to each organization is based on its membership level:

  • Seedling: No guaranteed committee seats. Participation may be available depending on committee capacity and selection.
  • Blooming: One guaranteed committee seat.
  • Evergreen: Three guaranteed committee seats.

NCIA will seek a balanced mix of cannabis operators, suppliers, service providers, and subject-matter experts whose professional experience aligns with each committee’s focus.

Members should also be prepared to make an active commitment to their committee. Expectations include:

  • Participating in monthly meetings and attending at least 75% of scheduled meetings.
  • Contributing relevant expertise, ideas, and support to committee priorities and projects.
  • Collaborating constructively with fellow committee members.
  • Remaining engaged between meetings when contributing to an active project or initiative.

Each committee will be led by a chair, with the option to appoint a vice chair. Committee leaders will help establish priorities, guide discussions, encourage participation, and coordinate projects with support from NCIA staff.

An important note for current committee members: The 2027 restructuring represents a new committee structure and appointment cycle. Existing committee participation does not automatically carry over.

All interested members, including those currently serving on NCIA committees, must submit a new application for consideration.

Committee appointments will be reviewed annually to help ensure that each group remains active, engaged, and aligned with member needs.

More Than a Seat at the Table

NCIA committees offer members an opportunity to play a more active role in the association and the broader cannabis industry.

Through participation, members can:

  • Build meaningful industry relationships by collaborating with business owners, executives, and professionals from across the cannabis ecosystem.
  • Share expertise and demonstrate leadership by contributing knowledge and experience to industry-wide conversations and educational resources.
  • Increase visibility for their organizations through committee projects, educational programming, articles, and other opportunities to showcase member expertise.
  • Stay connected to emerging industry challenges by exchanging perspectives with professionals navigating similar business and operational environments.
  • Help shape the industry’s future by contributing practical knowledge and solutions that support the continued development of the cannabis business community.

NCIA’s committees will focus primarily on practical business education, peer connection, and member-driven projects. The association’s established leadership and advocacy channels will continue to guide its policy and advocacy work, with committee members encouraged to stay connected to those efforts and participate in opportunities such as NCIA Lobby Days.

Apply Today: Help Shape NCIA’s 2027 Committee Program

The success of NCIA’s committees depends on the knowledge, experience, and active participation of its members.

As we introduce this new structure, we’re looking for engaged professionals who are ready to contribute, collaborate, and help turn shared industry challenges into meaningful opportunities for progress.

Whether you’re interested in sharing your expertise, developing educational resources, building relationships with fellow industry professionals, or helping guide the priorities of your sector, we encourage you to apply.

2027 NCIA Committee Applications Are Now Open!

APPLY FOR A 2027 NCIA COMMITTEE

Not yet an NCIA member? Explore membership options and benefits to learn how your organization can get involved.

Questions about committee participation or the application process? Contact Committees@theCannabisIndustry.org.

We look forward to building the next chapter of NCIA’s committee program together!

Committee Blog: Access to Capital in the U.S. Cannabis Market Outlook

Access to capital in the U.S. cannabis industry is undergoing a structural shift. While federal prohibition continues to constrain institutional participation, momentum towards Schedule III reclassification for medical marijuana, state-level regulatory modernization and emerging product categories are reshaping investor psychology, capital flows and increasing M&A activity.  However, the recent Administrative Law Judge (ALJ) granting the stay in the rescheduling proceedings continues to test investor resolve.  While the structural shift is expected to help current operators who have faced capital scarcity, led by price compression, regulatory uncertainty and lender caution, the delay creates uncertainty on the timing of a final DEA ruling and full implementation into Q4 2026 and possibly into Q1 2027.  While new opportunities are also expected to emerge in hemp-derived THC, beverages, distressed asset acquisition and operational modernization, as price compression is driving operational excellence, this added level of timing and uncertainty will likely keep investors on the sidelines until a Final Rule is issued and survives anticipated litigation risks.  

The industry has shown continued performance, with U.S. legal sales (THC + hemp-derived) was estimated at $36 billion on 2025 and is expected to reach $40 billion by 2027.  Hemp-derived THC beverages surpassed $1 billion in annual sales and is becoming the fastest growing category in the broader cannabinoid market.  Hemp-derived THC has also become a “capital magnet” due to lower regulatory friction, albeit risks from the upcoming December intoxicating-hemp ban, national distribution potential and strong consumer adoption.

While addressing industry trends and opportunities, it is also important to look at the current and future potential investor base.  Currently, founder capital and friends and family financing is still the backbone of the industry.  Financial institutions (banks and credit unions) have become sources of capital and private lenders, REITs and BDCs (business development companies) have also emerged as external sources of financing.  The latter tends to come with higher financing rates, shorter maturities and tighter covenants and in some cases, borrowers are asked for personal guarantees.  Debt financing remains the main source of financing, but structures are flexible.  Recent transactions, including a highly publicized $500 million secured note, highlighted the emergence of institutional participation.  Structural challenges and potential removal of regulatory uncertainty are expected to bring in a greater share of institutional participation.  Federal policy and uncertainties revolve around the timing of Schedule III implementation, Congressional action on SAFE (SAFER) banking, state-level enforcement of hemp-derived THC and diverging state licensing frameworks.  

The base case outlook is for Schedule III implementation, partial banking normalization, growth in new/emerging products and moderate to increasing institutional participation.  Equity financing, which has been limited, may also reemerge due to valuation readjustments and reduced investor caution.  The timing has shifted and could while the worst-case scenario (e.g. overhaul rescheduling proceedings), the opportunities should still promote operational excellence and strategic positioning ahead of regulatory modernization.  Operators should strengthen compliance and governance by cleaning their financial reporting, strengthen compliance systems, scale operational infrastructure and document SOPs and be audit ready.  Industry participants should improve operational efficiency by automating manual-intensive processes, optimize supply-chain channels and rationalize product lines and SKUs.  These factors directly influence lender confidence.  

Consolidation and distressed asset acquisitions are also accelerating.  Well-capitalized operations can acquire assets at discounted valuations.   M&A activity, which had been dominated by larger MSO activity, is also expected to grow with potential rescheduling as relief from 280E is expected to significantly improve earnings.  This improved outlook and cash flow and capital efficiency will again help investor sentiment.  

The cannabis industry is entering a pivotal period.  While capital access remains constrained, regulatory momentum, operation innovation and emerging product categories are creating new pathways for growth.  Operations who invest in compliance, efficiency, and strategic positioning ahead of regulatory headwinds will be best placed to capture the next wave of opportunities and increasing institutional participation.

Member Blog: The Risks of Removing a Regulated Cannabis Market

“Injustice anywhere is a threat to justice everywhere…” MLK Jr. 1963

As an insurance and risk-management professional working with cannabis businesses across the country, I spend my career asking a basic question: When risk exists, how do we identify it, reduce it, transfer it and hold people accountable for managing it?

Cannabis presents real risks. Youth access matters. Impaired driving matters. Product potency and contamination matter. Workplace safety matters. And businesses that fail to follow the rules should be held accountable, i.e., the illicit market.

Those concerns deserve serious attention.

But Massachusetts voters considering Question 8 this November should also consider a different risk-management question:

If the risk remains, what happens when we remove much of the regulated marketplace designed to manage it?

Question 8 would repeal Massachusetts laws legalizing, regulating and taxing retail adult-use cannabis. Existing adult-use retailers could seek expedited conversion to medical dispensaries, while the medical cannabis system would remain. The measure would take effect January 1, 2028. 

But cannabis itself would not disappear.

Adults 21 and older would still be permitted to possess up to one ounce of marijuana, including no more than five grams of concentrate, and could transfer that amount to another adult. 

That distinction matters.

The relevant public-policy question isn’t simply whether cannabis carries risk. It does. The harder question is: Which system gives Massachusetts more tools to manage that risk and hold market participants accountable?

In my profession, regulation is part of risk infrastructure.

A regulated cannabis marketplace establishes identifiable businesses operating under licenses and subject to rules and oversight. It creates a framework in which product testing, labeling, age restrictions, security, compliance, contracts, insurance and regulatory enforcement can operate.

Insurance is only one part of that infrastructure, but it illustrates the principle. When a licensed business purchases product liability, general liability, property, workers’ compensation or other coverage, insurers evaluate exposures and impose underwriting requirements. Businesses may be required to maintain security systems, follow safety protocols, document operations and meet other conditions of coverage.

That doesn’t eliminate risk. It makes risk visible and creates accountability for managing it.

Question 8 also raises an important issue for Massachusetts’ social-equity entrepreneurs.

The Commonwealth established its Cannabis Social Equity Trust Fund to expand participation in the regulated industry by entrepreneurs from communities disproportionately harmed by marijuana prohibition and enforcement. Massachusetts law directs a portion of marijuana revenue deposited into the Marijuana Regulation Fund to the trust fund. 

These entrepreneurs have built businesses under a regulatory framework created by the Commonwealth. They have pursued licenses, raised capital, leased or purchased property, hired employees, purchased insurance and invested in compliance.

Changing that framework therefore has consequences extending beyond cannabis products. It affects businesses, employees, vendors, landlords, professional-service providers, municipalities and communities that have built economic relationships around a legal marketplace.

There is also a direct fiscal consequence. According to Massachusetts’ official voter information, adult-use cannabis generated approximately $280 million in state tax revenue and $50 million in local revenue in fiscal year 2025. Question 8 would eliminate those adult-use cannabis tax revenues. 

None of this means Massachusetts’ existing cannabis system should be immune from scrutiny.

Quite the opposite.

If evidence demonstrates problems involving youth access, high-potency products, impaired driving, marketing practices, product safety or enforcement, policymakers should examine those problems seriously. Question 8 supporters have raised public-health and workplace concerns, while opponents argue that eliminating licensed adult-use sales would weaken existing safeguards. Massachusetts voters deserve an evidence-based examination of those concerns. 

Good regulation is not static. It evolves.

Testing standards can improve. Packaging requirements can change. Enforcement can become stronger. Education can become more effective. Insurance requirements can evolve as new risks emerge. Regulators can address businesses that fail to meet their obligations.

Massachusetts voters are therefore confronting something larger than a debate over whether they personally approve of cannabis.

They are deciding what framework should govern a substance that will remain present in the Commonwealth.

From a risk-management perspective, that distinction is critical. Eliminating a regulatory structure does not, by itself, eliminate the underlying risk. Consumer demand, public-health concerns and the need for accountability do not simply disappear with licensed storefronts.

Whatever Massachusetts decides, the policy conversation should begin with an acknowledgment that cannabis carries risks—and then ask which tools can most effectively identify, mitigate and manage them.

The existence of risk is not an argument against regulation. It is the reason regulation exists.

Federal Cannabis Policy Is Moving. What Does It Actually Mean for Your Business?

Federal cannabis policy is changing quickly.

Between developments around rescheduling, changes to the federal definition of hemp, evolving FinCEN guidance, and questions about banking and insurance, there is no shortage of headlines for cannabis businesses to follow.

But headlines alone do not tell businesses what they should actually do.

That was the focus of NCIA’s September Member Town Hall, “Federal Cannabis Policy in Flux: What Businesses Need to Know Now,” which brought together experts in federal policy, cannabis law, banking, and insurance to look beyond the headlines and examine the practical implications for businesses.

One theme emerged throughout the conversation:

Businesses need to understand what has actually changed, what remains unresolved, and what they may be assuming has changed before taking action.

Here are several of the key issues businesses should be watching.

Rescheduling: What Has Changed, and What Hasn’t?

One of the most important distinctions discussed during the Town Hall was that “rescheduling” is not a single development with a single set of consequences.

The panel distinguished the federal action affecting state medical marijuana programs from the separate, ongoing process concerning broader rescheduling of non-medical marijuana.

Eric Berlin of Dentons explained that the final rule affecting state medical marijuana programs is in effect, placing those programs in Schedule III and creating a DEA registration pathway for state-licensed medical marijuana operators.

The discussion also highlighted one immediate business implication: the potential effect on Section 280E for state-licensed medical marijuana operators.

At the same time, the broader rescheduling process remains unresolved.

For businesses, that distinction matters.

A federal action that is already legally effective should not be treated the same way as a proposal, pending proceeding, or potential future change.

The takeaway: Before changing a business strategy based on a federal policy headline, determine exactly what action has occurred, what remains pending, and which businesses or activities are actually affected.

Hemp: Definitions Can Have Real Business Consequences

The federal treatment of hemp-derived products was another area of discussion, particularly as changing definitions intersect with marijuana policy and implementation.

At first glance, a change in statutory or regulatory language may seem like a narrow legal issue. In practice, definitions can have consequences far beyond regulatory classification.

They can affect how products are viewed by regulators, financial institutions, insurers, vendors, and other business partners.

That means businesses should consider more than simply asking whether a particular product qualifies as hemp.

They should also ask:

What does that classification mean for the relationships and obligations surrounding the business?

This is especially important as businesses navigate an environment where federal policy, implementation, and industry practices may not all move at the same pace.

A Federal Policy Change Doesn’t Automatically Change Your Bank’s Policy

For many businesses, one of the most practical portions of the discussion focused on banking and financial services.

Susan Crum of Dart Bank emphasized an important distinction: a change in federal policy does not automatically translate into a policy change at every bank, credit union, payment processor, or lender.

Financial institutions have their own compliance programs, risk management frameworks, board oversight, and risk appetites.

As a result, even when federal policy changes, individual institutions may need time to evaluate what those developments mean for their organizations and determine whether they will adjust their policies.

For businesses, that means a headline announcing a federal change should not automatically be interpreted as a promise of expanded access to financial services.

Instead, communication becomes especially important.

Businesses should consider reaching out directly to their financial institutions to:

  • Ask whether policies or requirements have changed
  • Discuss upcoming changes to the business or its operations
  • Confirm that documentation about the business remains accurate
  • Understand how the institution currently views the company’s activities

The goal isn’t necessarily to react to uncertainty. It is to make sure the business and its financial partners understand each other’s expectations.

Don’t Overlook the Third Parties Behind Your Business

Another important theme from the discussion was the role of third-party relationships.

A business may understand how a federal development affects its own operations, but that does not necessarily tell the whole story.

Consider the companies and professionals that support the business:

  • Banks and lenders
  • Payment processors
  • Insurance carriers
  • Legal and compliance advisors
  • Vendors and service providers
  • Investors and other financial partners

Each of these organizations may have its own interpretation of regulatory developments and its own risk-management requirements.

That creates a broader question for business leaders:

If federal policy changes, what does that mean for the companies I rely on?

This is an important part of regulatory preparedness that can easily get overlooked.

Insurance: Read the Policy Before You Need It

Insurance was another area where the panel encouraged businesses to take a closer look at what they already have in place.

Summer Wilson-Jenkins of Carma Cannabis Insurance emphasized the importance of understanding policy definitions, exclusions, and coverage conditions rather than assuming that a policy provides coverage simply because the business has purchased it.

This can become particularly complicated for businesses operating around cannabis and hemp.

Terms such as “cannabis,” “hemp,” and “THC” can appear in policy language in ways that create questions about how coverage applies to a particular business or activity.

Those questions may become even more important for businesses that operate adjacent to the plant-touching sector or handle hemp-derived products.

The practical recommendation is simple:

Review your policy before you have a claim.

Businesses should understand what is covered, what is excluded, and whether the policy accurately reflects what the business actually does.

And when the language is unclear, ask an expert.

Five Questions Businesses Should Be Asking Right Now

The Town Hall ultimately pointed toward a practical approach to navigating federal uncertainty.

Rather than waiting for every question to be resolved, businesses can begin by asking:

  1. What has actually changed?
    Separate completed federal actions from proposed, pending, or potential future developments.
  2. What remains unresolved?
    Understand where additional regulatory, legal, or administrative action is still required.
  3. Has my financial institution changed its policy?
    Don’t assume that a federal development automatically changes your bank, lender, or payment processor relationship.
  4. Does my insurance actually cover what I’m doing?
    Review definitions, exclusions, and coverage conditions with someone who understands the business and the policy.
  5. Have I talked with the right experts?
    Legal, banking, insurance, and compliance questions increasingly overlap. No business owner is expected to navigate all of them alone.

The Bigger Takeaway

The federal cannabis landscape will continue to evolve, and not every question will be resolved at the same time.

But businesses do not necessarily have to wait for every answer before preparing.

Understanding what has actually changed, maintaining open communication with key service providers, reviewing contracts and policies, and working with qualified professional advisors can all help businesses navigate uncertainty more deliberately.

As the panel discussion made clear, even experts need experts. Legal, banking, insurance, policy, and operational risks increasingly intersect, making trusted relationships and reliable information more important as the federal landscape develops.

Continue the Conversation With NCIA

These are just a few of the practical takeaways from NCIA’s September Member Town Hall, “Federal Cannabis Policy in Flux: What Businesses Need to Know Now.”

The full conversation went deeper into federal rescheduling, hemp policy, FinCEN guidance, banking relationships, insurance coverage, third-party risk, and the practical steps businesses can take as the landscape continues to change.

Want to hear the full discussion? Access the Town Hall recording to hear directly from experts and gain additional perspective on the federal developments shaping the cannabis industry.

NCIA members have access to the recording and exclusive member resources through their membership. Not yet a member? Request access to the Town Hall recording and schedule a call to learn more about how NCIA helps cannabis businesses stay informed, strengthen industry relationships, and shape the policies that affect their future.

Before You Build: 5 Lessons for Cannabis Facility Success

Building or expanding a cannabis facility is a complex undertaking. From site selection and regulatory requirements to design, construction, equipment, and long-term operations, decisions made early in the process can have significant consequences later.

At NCIA’s recent Committee Insights webinar, Raising the Standard: How Team Experience, Collaboration, and Project Delivery Define Cannabis Facility Success, industry experts Jim Megerson of Anvil Agrinomics, Cary Richardson of Miles Construction, and Jeremy Schlicher of Urban Green Design explored how cannabis businesses can build stronger project teams, make better decisions earlier, and avoid costly problems before they reach the field.

Here are five key lessons from the conversation.

1. Build the Team Before You Build the Facility

One of the clearest themes from the discussion was that successful facility projects start with the right people.

As Cary Richardson put it, “The most important component of a project is the team building it.”

That team should be involved as early as possible, ideally beginning during site selection and due diligence. Bringing architects, engineers, contractors, and other qualified professionals into the process early can help identify issues before an owner commits to a property or design direction.

For cannabis businesses, that early involvement can be especially important. A seemingly attractive property may present challenges involving zoning, parking, electrical capacity, water supply, roof capacity, existing building conditions, or other site-specific requirements.

The lesson is straightforward: assemble the right team before making decisions that are difficult or expensive to reverse.

2. Evaluate the Property Before You Buy or Lease It

A recurring point throughout the conversation was the importance of professional due diligence before acquiring or committing to a facility.

A property that appears suitable on paper may not be suitable for the intended operation.

Questions around power, water, transformers, structural capacity, parking, zoning, environmental conditions, equipment requirements, and local regulations can all affect whether a site can support a cannabis operation efficiently.

Those issues are generally less expensive to address during due diligence than after a purchase, lease, or construction project is already underway.

For owners, operators, and investors, the takeaway is simple: Don’t let the real estate decision get ahead of the facility strategy.

3. Cannabis Facilities Require Specialized Expertise

Cannabis facilities can involve many of the same disciplines found in conventional commercial construction, but the operational requirements can be significantly different.

The panel discussed the importance of understanding everything from product flow and environmental controls to airlocks, receiving areas, CO₂ systems, MEP coordination, cultivation and production requirements, and the regulatory environment surrounding cannabis operations.

Local expertise also matters. State and local requirements, zoning, permitting, climate, floodplain conditions, professional licensing, and construction practices can vary significantly from one market to another.

The strongest project teams may therefore combine cannabis-specific experience with local expertise rather than assuming that one type of experience automatically covers all of the project’s needs.

4. Design Decisions Are an Investment, Not an Expense

The panel also emphasized the value of getting the design and construction documents right before work begins in the field.

As Jeremy Schlicher noted, it is much less expensive to identify and resolve a problem in a 3D model than to discover it after construction has begun and then tear something out and rebuild it.

That same principle applies to coordination, scope development, and value engineering.

Value engineering should not simply mean cutting costs after the design is complete. Instead, it can be an ongoing collaborative process throughout design that helps the team identify better ways to achieve the owner’s goals while considering cost, schedule, functionality, and long-term performance.

Investing more time and expertise on the front end can help reduce expensive changes and surprises later.

5. The Project Delivery Method Can Shape the Outcome

There is no single project delivery method that is right for every cannabis facility.

The panel explored several approaches, including Design-Bid-Build, Design-Build, Construction Manager at Risk (CMAR), and Integrated Project Delivery (IPD).

Each approach can create different relationships among owners, architects, engineers, contractors, and other project participants, affecting when team members become involved, how risk is allocated, how costs are managed, and how decisions are made.

The important question is therefore not simply, “Which delivery method is best?”

It is: Which delivery method best aligns with the project’s goals, timeline, risk tolerance, budget, and desired level of collaboration?

That decision is worth considering early, rather than defaulting to the approach used on a previous project.

The Bigger Lesson: Better Outcomes Start Earlier

The June NCIA Committee Insights session, Lessons Learned: Hidden Challenges in Cannabis Facility Design and Construction, explored some of the problems that can emerge during cannabis facility projects.

The October conversation took the next step: How can owners and project teams prevent those problems before they happen?

The answer starts with earlier decisions.

Bring the right people to the table. Evaluate the property before committing to it. Combine specialized cannabis knowledge with local expertise. Invest in thoughtful design and coordination. And choose a project delivery strategy that supports the way the team needs to work together.

For cannabis businesses planning a new facility, renovation, expansion, or major capital project, those decisions can have an impact long before construction begins.

The goal isn’t simply to build a facility. It’s to build the right facility, with the right team, using the right process.

Continue the Conversation

Want to hear the full discussion?

Watch the recording of NCIA’s Committee Insights: Raising the Standard: How Team Experience, Collaboration, and Project Delivery Define Cannabis Facility Success for additional insights from Jim Megerson, Cary Richardson, and Jeremy Schlicher.

NCIA members can also stay connected through NCIA’s Facilities Design Committee and ongoing educational programming focused on the issues shaping cannabis businesses and the broader industry.

Committee Blog: Preparing for Potential Changes to Federal Hemp Policy—and the Financial Implications for Businesses

Federal hemp policy is on the verge of its biggest shake-up since the 2018 Farm Bill—and businesses that prepare now will be the ones that survive the transition. The U.S. hemp industry has grown far beyond its original intent, driven largely by hemp-derived intoxicating cannabinoids like delta-8 THC, delta-10, and THC beverages. As these products reach mainstream consumers—and compete directly with state-regulated cannabis—federal agencies and lawmakers are signaling that policy tightening is coming.

Federal law passed in November 2025 redefines hemp and imposes sweeping restrictions. Congress has only delayed the effective date from Nov. 12 → Dec. 11, 2026 via a stopgap funding bill signed by President Trump. However, on November 12, 2026, products containing cannabinoids not naturally produced by the cannabis plant lose hemp status. This includes many synthetic or lab-made cannabinoids. As of today, on December 11, 2026, the rest of the ban takes effect — covering ~95% of intoxicating hemp products. 

Businesses across cultivation, processing, manufacturing, retail, and distribution must prepare for a future where federal rules may reshape product legality, taxation, compliance requirements, and market access. Lawmakers are considering expanding the definition of hemp to include total THC, not just delta-9. This would dramatically impact Biomass compliance testing, extraction and conversion processes and shelf-ready product formulations.  If total THC becomes the standard, many current products would be reclassified overnight.  Congress and federal agencies are evaluating limits or outright bans on Delta-8 THC, Delta-10 THC, THCP and other synthesized or converted cannabinoids.

This will have financial implications for Hemp businesses. Compliance costs are expected to increase as operators expect higher spending on testing, quality assurance, legal review, packaging updates and facility upgrades. If intoxicating cannabinoids are restricted, product portfolio risks include margin compression, inventory write-downs and reformulation costs to comply with new thresholds.  

Regulatory uncertainty typically causes lender and investors to tighten capital access, or slow investing timelines, and in turn, could lead to higher interest rates, more collateral requirements and shorter debt tenors. Risk appetite should be monitored as once regulatory uncertainty turns into sensible policy; capital markets typically return.  There is an underlying expectation of increased M&A activity due, but not limited to, distressed asset sales, consolidation among brands and producers and roll-ups of compliant operators. This may be an opportunity for operators with strong compliance and balance sheet management, becoming an acquisition target. Insurance and Banking services could increase services and expand coverage once new federal policy is implemented.

Current hemp businesses are advised to address their current operations and start with a risk mitigation strategy, aimed at an internal review of product exposure, manufacturing processes and related labeling and marketing claims. Furthermore, operators should update financial statements, forecasting and cash-flow management as costs are expected to increase to remain compliant. Input into scenario analysis/risk mitigation should include scenarios for Total THC compliance, Delta-8 restrictions and QA cost increases. Compliance infrastructure is critical and would also include additional investment into such requirements as GMP certification, independent product testing and SOPs. Some operators are also considering diversifying product SKUs to non-intoxication cannabinoids or partnering up with state-licensed cannabis operators.  

Quoting a recent article headline, “The Operators who prepare now will lead later.” Federal hemp policy is poised for meaningful change. While uncertainty creates short-term financial pressure, it also sets the stage for a more stable, investable, and scalable hemp industry. Businesses that proactively strengthen compliance, diversify products, and build financial resilience will be best positioned to thrive in the next regulatory era.

Committee Blog: Budtenders Make or Break Your Business – A No-Nonsense Guide to Cannabis Retail Staffing

In cannabis retail, your team is your brand. A well-stocked store with a poorly trained staff will lose to a leaner operation with great people every single time. Here’s what actually moves the needle when it comes to building and keeping a winning team.

Hire for Attitude, Train for Knowledge

Product knowledge can be taught — genuine warmth and a customer-first mindset are much harder to develop. Look for candidates who are naturally curious, communicate well under pressure, and genuinely enjoy helping people. The cannabis consumer base is wider than most new operators expect: seniors, medical patients, first-timers, and seasoned enthusiasts all walk through your door. Your staff needs to meet each of them where they are, without judgment.

Compliance Isn’t Optional — Make It Cultural

State and local regulations aren’t a box to check at onboarding — they’re an ongoing responsibility. Age verification, purchase limits, and documentation requirements need to be second nature for every person on your floor. Build compliance into your weekly rhythms, not just your new hire packet. When regulations change (and they will), your team should hear it from you first.

Invest in Real Product Education

Customers lean on budtenders for guidance, and generic answers lose sales and trust. Platforms like Learn Brands offer structured, brand-specific training that keeps your team sharp without eating up your management bandwidth. Layer that with vendor-led sessions when new products hit your shelves. A budtender who can confidently walk someone from “I don’t know where to start” to “this is exactly what I needed” is worth their weight in top-shelf flower.

Run Your Floor Like a Retail Operation

Cannabis retail is retail. Schedule around your traffic patterns, cross-train staff to handle multiple roles, and hold your team to consistent service standards from the moment a customer walks in to the moment they walk out. Establish a clear sales flow — needs assessment, recommendation, upsell where appropriate, and an educated send-off — and make it consistent across every shift and every employee.

Keep Them Growing — or They’ll Leave

Turnover is expensive and disruptive. Invest in your people with clear career paths, performance-based incentives, and a culture where good work gets recognized. The operators who retain their best budtenders treat the role as a real career, not a placeholder job. Regular team huddles, open feedback loops, and visible upward mobility go a long way in a competitive labor market.

The Bottom Line

Your staff will shape every customer experience, every compliance outcome, and ultimately your reputation in the market. The retailers winning long-term aren’t just well-capitalized — they’re well-staffed. Build your team with the same intentionality you bring to your product selection and store design, and the rest tends to follow.

Member Blog: Guaranteeing the First Loan

Cannabis has a serious credit problem. New York is where that failure is most recent and easiest to see. The obvious fix is already available.

New York licensed hundreds of small outdoor farmers on a promise. The Marihuana Regulation and Taxation Act (“MRTA”) commits the state to strengthen its agriculture sector. It names distressed farmers as a priority group. The farmers did their part. They got licensed. They planted. Every October they harvest, cure, weigh, tag, and stack the flower in a barn, all at the same time, causing a temporary over-supply.

Each farm sells alone into a wholesale commodity market without any market infrastructure or liquidity. One phone call at a time. That biomass is a year of income. It loses value every month. A farmer with rent due in November and planting coming quickly in spring has no leverage. The farmer sells at a discount or waits.

The license itself is part of the problem. New York caps outdoor canopy at 100,000 square feet. That revenue base cannot cover the processing, packaging, marketing, sales, and compliance costs of bringing a branded product to market.  Each piece of the supply chain is a full-time job that each farmer tries to do alone, or higher employees the farm cannot afford. Every outdoor farm faces the same choice. It carries overhead it cannot support, or it sells biomass at the buyer’s price. Aggregation is not a preference. The economics require it.

The economics favors outdoor production for every product but top-shelf, craft, loose flower.  An outdoor canopy costs $15 to $50 per square foot to build. An indoor room costs $500 to $1,000. Outdoor flower comes off the field at $50 to $200 a pound. Indoor runs $300 to $1,000. And quality is subjective; reasonable palates can disagree. A 2023 Columbia University study grew genetically identical clones indoors and outdoors. The sun-grown samples carried more terpenes, more minor cannabinoids, and fewer degraded ones. A 2025 life-cycle assessment in One Earth found that moving cultivation outdoors could cut industry emissions by up to 76 percent. Outdoor cultivation costs less, produces better chemistry, and emits less carbon. It is also going out of business.

Why?

It cannot borrow.

The fix is in New York Law

New York’s own Social and Economic Equity Plan concedes that most financial institutions will not lend to cannabis businesses. The Office of Cannabis Management’s 2024 equity report carries the heading “Underwrite Default and Loan Loss Risks for Commercial Lenders.” The report describes no program. No funded reserve. No first-loss percentage. No eligible-lender standard. No claims process.

The state runs the mechanism in other contexts. Empire State Development operates a Capital Access Program. The borrower and the lender each pay a small premium into a reserve account at the bank. The state matches that premium up to 7 percent of principal. The reserve repays the lender if a loan defaults. The lender makes every credit decision. The state never meets the borrower. The state’s energy authority uses the same tool for clean energy lending.

That instrument is a loan-loss reserve. It is the most conservative tool in public finance.

New York already holds the money and the authority. State Finance Law § 99-ii directs cannabis tax revenue to incubators and “other assistance” for equity applicants. The statute expressly includes low and zero-interest loans. The state may lend directly and carry all the risk. It may also do the cheaper thing and cover a fraction of a loan a regulated bank makes.

This is not a bailout. It is not another state-run fund. New York tried a state-run fund. The Social Equity Investment Fund borrowed at 15 percent. It passed 13 percent loans to retailers on build-outs those retailers did not control. It financed roughly 21 stores. It stopped lending in 2024. Its borrowers now seek restructuring. That failure was structural, not personal. The state should cover the lender’s risk. It should not choose the borrower’s site, contractor, or price.

Test Case Proposal

The latest white paper from Cogent Law Group proposes a test. Fund a modest reserve. Guarantee one loan to Certified Sun Grown Collective (“CSGC”), a farmer-governed cooperative that pools members’ biomass, sells it at collective scale, and returns the margin to the farms. CSGC holds no license. It asks the state for no check. A reserve that makes this loan bankable makes the next hundred bankable.

Most states face the same problem with the same tools. They collect cannabis tax revenue. They run economic development authorities that already provide credit enhancement to other industries. They license operators no bank will finance. Existing programs have proven the instrument. The money exists. No state has funded a cannabis reserve.

The paper lays out the statutory and constitutional case. It explains what the last program got wrong. It analyzes the banking regulations under the 2014 Financial Crimes Enforcement Network guidance that still governs cannabis lending. We identify the weakest points in our own argument. We want responses more than praise.

Read or download the full white paper at Cogent Law Group.

The farmers did their part. The crop is in the barn.

Now the state should guarantee one loan.

Beyond Rescheduling: Inside NCIA’s 14th Annual National Cannabis Industry Lobby Days

Momentum matters. So does showing up.

From May 12–14, 2026, cannabis business owners, operators, and advocates from across the country gathered in Washington, D.C. for the National Cannabis Industry Association’s 14th Annual National Cannabis Industry Lobby Days. Over a day and a half, NCIA members brought the realities of running a state-legal cannabis business directly to Congress at one of the most consequential moments for cannabis policy in decades.

The message was clear: historic progress has been made, but the work is far from finished.

This year’s Lobby Days came just weeks after the U.S. Department of Justice’s April final order rescheduling state-regulated medical cannabis to Schedule III of the Controlled Substances Act. For many in the industry, it marked a long-overdue acknowledgment of medical cannabis and the legitimacy of state programs. But as conversations on Capitol Hill quickly revealed, rescheduling also created new questions, uncertainty, and urgency.

Congress still has work to do.

Bringing Clarity to a Changing Policy Landscape

Over the course of 78 meetings, 71 participants representing 25 states and Washington, D.C. met with congressional offices and committee staff during one of the busiest legislative weeks on Capitol Hill.

Participants represented a broad cross-section of the cannabis economy, from cultivators, manufacturers, and retailers to ancillary businesses, financial professionals, and service providers. Together, they brought real-world experience into offices representing adult-use, medical, and emerging markets, as well as states without regulated cannabis programs.

What emerged from those conversations was revealing.

Even among long-time congressional champions, many offices were still navigating what April’s rescheduling order actually means in practice.

Would tax fairness finally become reality? How would medical and adult-use markets interact under a partially rescheduled framework? What role would Congress play if litigation delays or disrupts implementation? How should federal law treat businesses operating across state-regulated systems?

These are not theoretical questions for cannabis operators. They are business realities.

That made constituent voices essential.

NCIA members used their lived experiences to help offices understand how continued conflicting state and federal policies affect hiring, investments, banking access, tax obligations, public safety, access, and the ability to compete against illicit operators who face none of the same burdens.

Policy conversations become stronger when lawmakers hear directly from the businesses operating in their own communities.

Lobby Days reinforced something we know well: progress happens when the people living the consequences of federal policy help shape the conversation around fixing it.

Turning Momentum Into Action

The focus of this year’s advocacy was straightforward: ensure Congress understands that rescheduling alone does not solve the structural challenges facing cannabis businesses.

NCIA members urged offices to support policies that protect state markets, provide certainty, and support regulated businesses competing against an untaxed, unregulated illicit market.

Conversations centered on bipartisan legislation such as the STATES 2.0 Act, which would align federal law with individual state cannabis policies and provide long-term certainty for both medical and adult-use markets. Members also discussed the need to protect ongoing rescheduling efforts from political or bureaucratic disruption while preparing federal agencies for the future of cannabis policy.

For operators, one issue consistently rose to the top: tax fairness.

While April’s rescheduling order could eventually provide relief from Section 280E for some state-regulated medical businesses, uncertainty remains for those holding dual licenses in medical and adult-use programs, adult-use operators, and other businesses awaiting implementation clarity.

During Lobby Days, NCIA members reinforced the need for immediate federal guidance and congressional action to prevent additional uncertainty for compliant operators already navigating narrow margins, rising costs, and inconsistent federal treatment.

In one example of that work, NCIA members met with congressional offices helping lead efforts to provide greater clarity on federal tax treatment following rescheduling, including Congressman Steven Horsford’s office, which is spearheading outreach to the Internal Revenue Service and Treasury Department regarding implementation guidance for qualifying state-legal cannabis businesses. These conversations reinforced the urgent need for certainty around Section 280E and tax treatment as operators navigate an evolving federal landscape.

Members also pressed offices to strongly oppose proposals that would permanently preserve punitive federal tax treatment for cannabis businesses regardless of future legal status, including efforts that would extend the burden of Section 280E even in the event of broader reform. For an industry already operating under extraordinary regulatory and financial constraints, codifying unfair tax treatment would move federal policy in the wrong direction.

Relationships That Move Policy

One of the strongest signals from this year’s Lobby Days was not simply support for reform. It was appreciation for partnerships.

Across meetings — including with longtime allies and newer offices — congressional staff repeatedly emphasized the value of having trusted industry constituent voices to help navigate fast-moving cannabis policy developments.

That relationship matters.

The cannabis industry has spent years operating in the gap between state legalization and federal prohibition. Progress requires more than headlines or hearing dates. It requires education, credibility, and consistent engagement.

Lobby Days exists to strengthen those relationships so that when legislative opportunities emerge, Congress already understands the stakes.

This year’s advocacy footprint reflected that commitment, with meetings spanning both Democrat and Republican offices. Whether the conversation centered on small business growth, public safety, states’ rights, veterans’ access, job creation, or creating a regulated market capable of outcompeting illicit operators, one thing remained clear: durable reform requires broad coalitions.

Recognizing Congressional Leadership and Service

Lobby Days also offered an opportunity to recognize leaders whose commitment continues to move cannabis policy forward through sustained action, partnership, and persistence.

This year, NCIA honored two congressional champions with our Legislator of the Year Award: Congressman Jerrold Nadler (D-NY-12) and Congressman Brian Mast (R-FL-21).

Congressman Nadler, who will retire at the conclusion of this congressional term, has spent years advancing federal cannabis reform and helping move the conversation from political possibility to legislative reality. As the longtime sponsor of the MORE Act, one of Congress’s most comprehensive proposals to end federal cannabis prohibition, Rep. Nadler has consistently championed policies aimed at modernizing federal law while addressing the lasting harms of prohibition. His leadership helped elevate cannabis reform from a fringe issue to a serious legislative conversation in Congress.

“I am honored to accept the Legislator Lifetime Achievement Award from the National Cannabis Industry Association. I am proud to have led responsible, commonsense cannabis reform legislation, such as the MORE Act, throughout my career in public office and look forward to continuing the fight for fair and equitable federal policy reform on this issue,” Congressman Jerrold Nadler (D-NY-12) said.

Congressman Mast, a combat-wounded veteran and co-chair of the Congressional Cannabis Caucus, has remained a leading voice for veterans seeking access to medical cannabis. Through efforts such as the bipartisan Veterans Equal Access Act, Rep. Mast has fought to ensure U.S. Department of Veterans Affairs physicians can discuss and recommend medical cannabis to veterans living in states where it is legal. His work reflects a broader commitment to ensuring those who served this country are not denied access to treatment options available to other Americans.

At a moment when cannabis reform continues to require bipartisan leadership, both lawmakers have demonstrated what meaningful engagement looks like: listening to constituents, advancing practical policy solutions, and staying committed to progress.

This year’s event also included a moment of recognition from within the organization itself. The NCIA Board of Directors presented the inaugural Heart of NCIA Award to Brooke Gilbert, Chief Operating Officer of NCIA, and Michael Cooper, NCIA’s Policy Chair, in recognition of their extraordinary loyalty, leadership, and dedication to the association’s mission and membership.

Advocacy is powered by relationships, trust, and people willing to do the work day after day. Strong industries are built not only through moments of visibility, but through the steady commitment required to keep moving forward.

The Work Ahead

Lobby Days is not an endpoint.

It is relationship-building in motion.

Every meeting on Capitol Hill helps shape future legislation. Every operator who shares their story helps lawmakers better understand the real-world consequences of federal inaction. Every conversation strengthens the case that regulated cannabis businesses deserve the same certainty, fairness, and opportunity as any other legal industry.

The cannabis industry did not get this far by waiting for permission. It moved forward because people organized, educated, and showed up.

To everyone who joined us for NCIA’s 14th Annual Cannabis Industry Lobby Days, thank you for continuing to move this work forward. We are stronger when we advocate together. And together, we will keep building what comes next.

Thank You To Our Sponsors

DOJ Reschedules Medical Cannabis to Schedule III & Announces June 2026 Hearing on Broader Rescheduling

The National Cannabis Industry Association (NCIA) applauds the Trump administration and the Department of Justice for finalizing the decision to move medical cannabis to Schedule III under the Controlled Substances Act while urging immediate action to complete rescheduling of cannabis and emphasizing the need for comprehensive reform. This action represents a significant and long-overdue first step in aligning federal policy with science, patient needs, and the realities of today’s regulated cannabis marketplace.

By formally recognizing cannabis’ accepted medical use, this decision helps correct a decades-old policy mismatch. It facilitates research and provides meaningful relief to state-licensed medical operators, particularly through the removal of tax burdens imposed by Section 280E. Rescheduling will allow responsible medical operators to reinvest in their workforce, strengthen compliance, and continue delivering safe, tested products to millions of patients.

NCIA specifically appreciates the Trump administration’s adoption of the retroactive 280E relief for state-licensed operators championed by NCIA and detailed in our 2025 white paper.  Retroactive 280E relief is essential to ensuring a level playing field for small businesses, and NCIA appreciates the Trump administration’s recommendation for state-licensed medical operators and urges that the same position be adopted for all state-licensed cannabis operators. 

The Trump administration must also move forward as quickly as possible to apply rescheduling to the entire industry through the hearings announced for June. By omitting adult-use operators in today’s rescheduling order, businesses selling identical cannabis products could be treated materially differently depending on the type of state license. Moreover, much of the market must continue to operate under an onerous taxation model even as medical operators have the opportunity to write-off common business expenses with the elimination of 280E.

NCIA will continue to support the rescheduling process as the administration continues to engage with stakeholders across the industry.   We view this as an important step toward a more rational and modern federal approach to cannabis.

At the same time, rescheduling is not the finish line. Congress must now build on this progress by establishing a clear federal framework that respects states’ rights, ensures public safety, and supports the long-term stability of the legal cannabis industry. NCIA remains committed to working with policymakers on both sides of the aisle to advance comprehensive reform.

Take Action: Help Turn Momentum Into Meaningful Reform

The decision to move medical cannabis to Schedule III represents a significant and long-overdue first step—but it is not the finish line.

With administrative hearings on broader rescheduling set to begin in June 2026, the path forward is clear: policymakers must ensure that these changes are applied fairly across the entire industry and that Congress builds on this progress by establishing a comprehensive federal framework that respects states’ rights, ensures public safety, and supports long-term industry stability.

That progress will not happen without sustained engagement from industry stakeholders.

Now is the time to show up.

Join NCIA in Washington, D.C. for our upcoming 14th Annual Cannabis Industry Lobby Days next month and help ensure that the voices of responsible cannabis businesses are heard as federal policy continues to evolve. Together, we can push for the comprehensive reform needed to create a more rational and modern approach to cannabis regulation.

For a limited time, register for Lobby Days at 50% off through the end of the weekend using code FLASH50.

Your participation is critical to ensuring that this moment leads to lasting change.

 

Member Blog: Solutions to Pre-Roll Cone Loading at Scale

By Harrison Bard, CEO and Co-Founder Custom Cones USA and DaySavers

The two slowest parts of the pre-roll production process are the beginning and the end. 

Closing pre-rolls is always the top pain point for manufacturers, which makers of the Fill N’ Fold cone-filling machine addressed with the creation of the tamping and folding tool they include with each machine.

But loading cones into a machine one-by-one at the beginning of every cycle is still also a consistent speed bump that limits throughput. And like with the tamping and closing tool, Fill N’ Fold has once again created a solution: The Fill N’ Fold Cone Dispenser, capable of holding towers of pre-rolled cones and dropping 121 at a time into a work tray.

It’s a pretty handy device and one of the smartest additions we’ve seen to the pre-roll machine market in a while. And with just a little practice, it can drastically increase your speed, reduce employee time spent on tedious, repetitive tasks and improve your overall pre-roll production numbers.

“Pre-Roll Machines have slowly been improving to address the needs of producers,” said Harrison Bard, CEO and co-founder of Custom Cones USA, a leading provider of pre-roll supplies and machines for the cannabis industry. “Loading cones is always one of the slow points in the line we hear complaints about and it’s exciting to see innovations like the Cone Dispenser to speed things up.”

What is the Fill N’ Fold?

The Fill N’ Fold cone-filling machine is a small, tabletop pre-roll machine that uses a vibrating motor to pack pre-rolled cones loaded into one of a series of work trays related to cone size. 

With space for 121 cones per cycle and time-saving additions like specially designed metering trays and the unique tamping/folding tool to close a full row of 11 pre-rolls at once, the machine is a trusted and easy way to launch or scale a pre-roll line. 

It also came out ahead in our Battle of the Pre-Roll Machines, outpacing a handful of other cone-fillers, mainly on the back end, where the tamping tool saved tons of time.

Until now though, individual empty cones had to be dropped into each cone slot by hand.

The Fill N’ Fold Cone Dispenser

The Fill N’ Fold Cone Dispenser solves the reload problem by using a unique latch mechanism that can hold a single cone in place by the filter without damaging it. 

The full system consists of two boxes (with an extension for larger cones) that fit directly on top of the machine’s work trays. Each box has a set of the latches that when closed, hold cones in place but when released let them slide through.

Producers can then load full tower-box stacks of cones into each slot of the top box and use the two-box system to drop a full run of 121 single cones into the lower box at once. Then the latches are re-engaged and the boxes are placed on top of the machine’s work tray and the top box is removed before the lower box’s latches are used to drop the cones directly into a work tray where they are ready to be filled. 

Then, they simply repeat the process for the next run. 

Used right, it can save a ton of employee time and drastically increase your pre-roll throughput.

Final Thoughts

The Fill N’ Fold Cone Dispenser comes with a stand to hold the machine and helps protect your un-filled cones from crushing while they wait to be loaded. 

It works with all major sizes of pre-rolled cones, including 70mm dogwalkers, 84mm half-grams, ¾-gram 98mm cones and full-gram 109mm cones, as long as the cone has a standard 26mm filter. 

Plus, it’s made with the same high-density plastic as the work trays and metering trays, so it’s easy to clean and store when not in use.

The Fill N’ Fold is already a great tabletop cone filling machine that won our Battle of the Cone-Filling Machines speed and output test thanks to innovative thinking to speed up the back half of production.

The addition of the Cone Loader to the Fill N’ Fold accessories arsenal only gives it another potential leg up on the competition when it comes to speeding up your pre-roll production line.

Committee Blog: The Cannabis Beverage Industry’s Credibility Gap And How Real-World Research Can Close It 

By Leah Kollross, Founder at 23rd State and NCIA Human Resources Committee Member 

Cannabis beverages are one of the fastest-growing segments in the broader cannabis and hemp marketplace. Consumers are reaching for infused seltzers, tonics, and drink enhancers at an accelerating pace, driven by curiosity about alcohol alternatives, shifting wellness norms, and the cultural momentum of the sober-curious movement. But here’s the uncomfortable truth many of us in this industry need to confront: growth alone doesn’t build trust. And without trust, this category is building on sand. 

As both a cannabis beverage operator and a member of NCIA, I occupy two vantage points that increasingly converge on one conclusion: the brands that will define this category long-term are the ones willing to validate their products through rigorous, independent research, not just the ones with the best packaging or the most compelling Instagram presence. 

The Credibility Problem We All Share 

Right now, most cannabis beverage brands make claims about their products: onset time, duration, consistency, mood effects, that are rooted in anecdotal feedback, internal testing, or simply what sounds good in marketing copy. That’s not a criticism of any single brand. It’s a structural problem across the entire category. We’re asking consumers, retailers, distributors, and regulators to take us at our word in a market where few players have invested in the kind of evidence base that other consumer packaged goods categories take for granted. 

This credibility gap has real consequences, less than 5% of cannabis beverage manufactures invest in validation. Retailers hesitate to allocate shelf space to products with unsubstantiated performance claims. Legislators drafting hemp and cannabis regulations lack the data they need to distinguish between well-formulated products and poorly made ones. And consumers who have a bad first experience, inconsistent effects, unexpected onset, or a product that simply doesn’t deliver, may not come back to the category at all.

What Real-World Research Actually Looks Like 

This is why research initiatives like MoreBetter’s Real-World Infused Beverage Study matter so much for the future of our industry. MoreBetter is a contract research organization that specializes in real-world data (RWD) collection for functional and consumer wellness products. Their ongoing Infused Beverage Study is one of the largest ever conducted on THC- and CBD-infused beverages, spanning multiple cohorts with over 5,000 participants, 20 brands, and a wide range of product formats. 

The study design itself is instructive. Participants consume infused beverages over a multi-week period and self-report daily on their alcohol use, mood, sleep, and perceived product effects. The first cohort yielded striking results: the probability of daily alcohol use among participants dropped meaningfully during the product-use phase, and the vast majority of participants reported that infused beverages felt safer than alcohol for their health. Nearly half of Cohort 1 participants were trying an infused beverage for the first time, a powerful signal that the category is reaching entirely new consumers, not just converting existing cannabis users. 

But the value of this research extends beyond headline statistics. As the study has progressed into its second cohort, the data has begun to reveal something even more significant: measurable, product-level differences in onset, duration, and consistency. Not all THC beverages perform the same way, and now there’s a dataset large enough to prove it. 

Why Operators Should Care And Participate 

At 23rd State, we made the decision to include our products in the MoreBetter study because we believe product validation isn’t just a marketing advantage, it’s an obligation to our consumers and to the broader industry. When you put your products through independent, real-world testing, you’re committing to transparency. You’re saying that your formulations can stand up to scrutiny, and that you trust the data to tell the story rather than relying exclusively on your own narrative. You can explore our approach and findings on research-validated-thc-beverages. 

For operators considering whether to invest in research participation, the benefits go well beyond brand credibility. Real-world data gives your retail and distribution partners something concrete to share with buyers. It gives you a foundation for responsible marketing claims. It provides your R&D team with actionable feedback on product performance. And it gives regulators and legislators evidence that the hemp-derived beverage category is capable of self-governance and quality standards, something the entire industry needs as regulatory frameworks continue to take shape at both the state and federal level.

Why This Is Personal 

I don’t approach product validation as an abstract business strategy. I approach it as someone living with multiple sclerosis. I was diagnosed with MS in 2023, the same year I founded 23rd State. Cannabis beverages gave me a way back into social moments without compromising my health. 

That lived experience is why I care so deeply about getting the science right. When a product makes a promise about onset, duration, or consistency, there are real people on the other end of that promise, people managing chronic conditions, people navigating medication regimens, people who have already had to give up enough and deserve to trust what they’re consuming. I wrote more about this journey for GreenState, and the response made one thing clear: the demand for trustworthy, research-backed cannabis beverages isn’t hypothetical. It’s deeply personal for a growing number of consumers. 

That’s exactly why independent validation matters. It’s not enough for me to believe our products perform well. I need to know it, and so do the people who depend on them. 

Building an Evidence-Based Category Together 

From my seat on the NCIA committee, I see the policy landscape evolving rapidly. Legislators are making decisions about how to regulate hemp-derived products, and they’re doing so with limited data. Every brand that participates in legitimate research studies contributes to a shared body of evidence that strengthens the entire industry’s position. We cannot ask for reasonable regulation while simultaneously refusing to produce the evidence that would support it. 

The infused beverage category is at an inflection point. We can continue to grow on promise and positioning, or we can build something more durable, a category grounded in measurable performance, consumer trust, and data-informed product development. Research participation isn’t a cost center. It’s an investment in the legitimacy and longevity of every business in this space. 

The brands that lead on evidence will lead the category. The question for the rest of the industry is whether they’re willing to submit their products to the same standard, and what it signals to consumers and regulators if they don’t.

Member Blog: Operational Change as an EHS Risk Signal

In cannabis operations, risk does not always show up where people expect to find it.

It does not always present as an incident, a regulatory issue, or a failed inspection. More often, it appears during periods of change—when something in the operation shifts, even if everything still seems to be working as intended.

A new piece of equipment is installed. Production increases. A workflow is adjusted to improve throughput. A material or process input changes. New employees or contractors are brought in to support growth. These are all normal, and often necessary, parts of running a successful operation.

They are also points where risk can change.

That does not mean change should be avoided. It means it should be recognized for what it is: a moment where assumptions, controls, and routines may no longer fully align with the way work is actually being performed.

In a fast-moving industry like cannabis, that awareness can make a meaningful difference.

When Risk Increases Without an Obvious Failure

One of the more challenging aspects of EHS is that risk can increase without any immediate indication that something is wrong.

No injury. No spill. No alarm. No near miss.

That absence of visible issues can create a sense of stability—especially in facilities where production is strong and day-to-day operations appear consistent.

But in many cases, risk does not increase because something breaks. It increases because conditions gradually shift.

A process begins operating at a higher pace or frequency. Maintenance is deferred to support production. Informal workarounds emerge to keep things moving. Temporary adjustments remain in place longer than intended. Over time, these small changes can accumulate.

What feels “normal” may no longer reflect the conditions the process or system was originally designed to support. This is where operational change becomes important—not as a disruption, but as an early signal.

Operational Changes That Deserve a Closer Look

Not every change introduces meaningful new exposure. But certain types of operational
change tend to have broader implications and are worth a closer look.

New or Modified Equipment

Installing new extraction, post-processing, packaging, ventilation, or utility equipment often affects more than the immediate task it was intended to improve.

It may also influence:
• airflow and ventilation patterns
• maintenance and inspection needs
• cleaning practices
• operator interaction points
• emergency response considerations

Even when equipment performs as expected, the surrounding system may need to adapt.

Increased Throughput or Production Demand

Processes that perform well at one pace may behave differently at another.

As production increases, organizations may see:
• more frequent changeovers
• reduced downtime for inspection or cleaning
• increased wear on components
• higher material handling volumes
• less margin for error

These are common operational realities, but they can also shift the conditions that safe performance depends on.

Material or Input Changes

Changes to solvents, cleaning products, ingredients, packaging components, or other inputs are often made for practical reasons.

However, even small substitutions can affect:
• compatibility
• storage practices
• ventilation needs
• PPE expectations
• waste handling
• fire or reactivity characteristics

Understanding how new materials interact with existing processes is an important part of managing change.

Staffing, Supervision, or Contractor Changes

Periods of rapid hiring, increased overtime, or contractor involvement can also influence
risk.

In these situations, it is helpful to consider not only whether procedures are in place, but whether the systems supporting the work—training, supervision, communication—are keeping pace with the people performing it.

The Signals Often Appear Before the Incident

A useful way to think about operational risk is this:

The incident is often not the first signal—it is the first one that cannot be ignored.

Before that point, there are often smaller indicators that something is changing.

These may include:
• workarounds becoming part of routine practice
• temporary fixes remaining in place longer than expected
• operators informally adjusting steps to maintain production
• maintenance becoming more reactive than planned
• repeated minor issues that are tolerated rather than investigated
• safety-related decisions being deferred during busy periods

Individually, these signals may not seem significant. Together, they can indicate that operations are evolving faster than the systems designed to support safe and stable work.

Recognizing these patterns early provides an opportunity to respond before issues escalate.

Why These Risks Can Be Easy to Miss

Many organizations rely on inspections, audits, and incident reviews to understand safety performance. These are important tools.

However, they are not always designed to answer a different—but equally important— question:

What has changed here recently—and what might that mean for risk?

This question shifts the focus from whether controls exist to whether they still reflect current operating conditions.

In dynamic environments, that distinction matters.

A facility can appear stable based on documentation or past performance, while underlying conditions are gradually changing. Without intentional attention to those changes, the gap between how work is designed and how it is actually performed can widen over time.

A Practical Approach to Recognizing Change

Recognizing operational change as a risk signal does not require complex systems. It often begins with building awareness into everyday decision-making.

When changes occur—whether related to equipment, staffing, workflows, or production— organizations can benefit from asking:
• What has changed recently?
• What are people doing differently now than they were six months ago?
• Where are informal workarounds being used?
• What are we accepting today that we may not have accepted previously?

These questions are not limited to EHS functions. They are part of effective operational leadership.

They help ensure that as the business evolves, the systems supporting safe and stable operations evolve with it.

Closing Thought

In cannabis operations, some of the most meaningful safety insights do not come from incidents, citations, or inspection results.

They come from recognizing when the operation has changed—and taking the time to understand what that change may mean.

As the industry continues to grow and evolve, developing that awareness can help organizations stay ahead of risk, rather than reacting after it becomes visible.

Member Blog: The Untapped Opportunity in Pre-Rolled Blunts

What if I told you there was a huge opportunity in the pre-roll category, a mostly untapped segment with a built-in customer base and an instantly recognizable product that drives millions of dollars in sales?

For years, the pre-roll category has been one of the fastest-growing segments in legal cannabis, totaling nearly $3.6 billion in sales in 2025 in the markets tracked by cannabis analytics firm Headset.  Consumers love the convenience, portability, and accessibility of pre-rolls, and retailers appreciate their consistent sell-through as low-cost, high-margin add-ons at checkout.

But within that booming category, one product type stands out as an underdeveloped opportunity: the blunt.

Blunts: A Classic Format with Modern Market Potential

Despite the innovations in vapes, edibles and other product forms since the early days of the industry, traditional smoking remains king. In fact, New Frontier Data found that about 60% of cannabis consumers still list the classic joint as their primary consumption method. 

But if you look a little deeper into the data, it reveals that the third most popular consumption method is the blunt, with 33% of respondents listing it as a go-to.

However, when we look at the actual sales data, blunts barely register. According to Headset, pre-rolled blunts currently make up less than 1% of total pre-roll sales. Of the $3.6 billion generated by pre-rolls in 2025, the “Cannagar/Blunt” segment accounted for roughly $16.3 million in sales.

However, because of how Headset parses the data, all infused blunts fall into the “connoisseur/infused” segment, not the blunt segment, skewing the final numbers.

When we look specifically at the products containing the word “blunt,” we get a clearer picture. Collectively, those “blunt” products sold 8.5 million units and generated more than $148 million in revenue nationwide.

That demonstrates a demand for the product. And for pre-roll producers and processors, that’s the definition of a growth opportunity. 

The Evolution of the Modern Pre-Rolled Blunt 

Traditionally, a blunt is a cannabis cigar; flower rolled in a tobacco leaf wrap instead of paper. The thicker wrap produces a slower burn, richer flavor, and a distinctive mouthfeel that many smokers prefer. The name itself comes from the “blunt” style of machine-rolled cigars, such as Phillies Blunts, which became synonymous with cannabis culture in the 1980s and ‘90s, thanks in large part to hip-hop’s East Coast icons.

But as part of their regulations, each modern cannabis market prohibits combining tobacco and cannabis products, which led to the development of nicotine-free blunt wraps designed to deliver the same slow burn and satisfying texture, but without the tobacco.

Today, most modern blunts are wrapped in hemp wraps, though tea leaf and botanical alternatives such as goji berry or palm leaf are also popular.  Modern, pre-rolled blunts also tend to include filter tips, whether standard pre-rolled joint like paper filters, spiral filters or even premium options like wood, glass and ceramic options, to cool the smoke and elevate the experience.

Pre-roll blunts can also be found in both tube and pre-rolled cone forms, with the latter being introduced to the market by Custom Cones USA, and are usually found in the 1-gram to 2-gram range, as blunt smokers tend to want longer smoking experiences.  

What Options Exist for Producers?

Brands looking to enter the blunt space have more options than ever. The first choice is shape – cone or tube – since that determines the filter style, filling process and production equipment.

Cone-style blunts, first introduced to the market by Custom Cones USA, are the easiest entry point for companies already producing joints. They’re compatible with standard cone-filling machines and use familiar “W-style” paper filters.

Tube-style blunts can open up a world of premium customization. They typically use larger filter tips (spiral paper, wood, glass, or ceramic) and can accommodate larger weights, making them ideal for high-end SKUs. However, a tube-filling conversion kit may be needed to adapt existing production lines, however.

After you’ve chosen a shape, the next question is what kind of wrap to use:

  • Hemp wraps: The industry standard for a reason; natural, slow-burning, and tobacco-free.
  • Hybrid hemp wraps: A Custom Cones USA innovation that retains the rich hemp flavor while resisting moisture and cracking. 
  • Tea leaf wraps: Offer subtle cocoa and vanilla notes for a smoother, lighter smoke.
  • Botanical wraps: Specialty options like goji berry add flavor and vibrant visual appeal.

Each wrap type can be paired with custom filter tips and cigar-style bands to reinforce brand identity on the shelf. 

Why The Pre-Rolled Blunt Category Matters

When you combine consumer preference (33% blunt users) with sales data ($148+ million and growing), the takeaway is clear: the blunt market may be underdeveloped, but it’s not underloved.

For producers, that means a Blue Ocean opportunity, a chance to claim early leadership in a space that’s ripe for innovation. With the right materials and machinery, transitioning from pre-rolls to blunts is straightforward, scalable and potentially brand-defining.

Whether you’re adding a new SKUs to your pre-roll line or launching a dedicated blunt brand, now is the time to invest and make a mark in this emerging segment.

Committee Blog: Where Medical Cannabis Meets Employer Benefits

The Cannabis Industry at a Crossroads

The legal cannabis industry in the United States was born from a movement rooted in compassion — a movement to provide safe access to a plant that patients had relied upon for decades to treat serious medical conditions.

Medical cannabis programs were the catalyst that launched today’s adult-use market, which is projected to exceed $50 billion in U.S. sales by 2030. Yet as adult-use markets expand, many state medical programs have quietly eroded — leaving patients with fewer protections, fewer tailored products, and fewer pathways to access cannabis as medicine.

This moment demands reflection.

The industry that built its foundation on patient care must ask itself a critical question:

Why should patients be left behind?

As federal policy begins to evolve — with the anticipated reclassification of cannabis from Schedule I to Schedule III — the industry has a rare opportunity to rebalance the ecosystem between medical and adult-use markets. Rather than competing systems, these markets should work together to elevate the credibility, legitimacy, and impact of cannabis as a therapeutic tool.

The Healthcare Crisis Demanding Innovation

At the same time the cannabis industry is evolving, the United States faces another crisis: the rising cost of healthcare.

Employers across both the public and private sectors are experiencing double-digit healthcare cost increases year after year. Human resource directors, municipal leaders, and business owners are forced to make difficult decisions about how to maintain coverage for employees while managing budgets.

Some employers attempt to mitigate risk through:

  • Self-insured health plans
  • Health Insurance Funds (HIFs)
  • Professional Employer Organizations (PEOs)
  • High deductible plan structures

Yet despite these strategies, healthcare costs continue to climb.

Recent events highlight the severity of the problem. Nurses at Presbyterian Hospital in New York City rejected a stipend rather than accept reductions to their healthcare benefits — a stark reminder that even those who deliver care struggle to afford it.

If the healthcare workforce cannot maintain access to healthcare benefits, the system itself is in danger.

Meanwhile, the nation continues to grapple with overlapping public health crises:

  • The opioid epidemic
  • Rising rates of depression, anxiety, and PTSD
  • Increasing chronic pain conditions
  • Escalating co-morbidities linked to lifestyle and environmental factors

Despite decades of effort and billions in spending, the opioid crisis alone continues to claim lives in every county in America.

The system is strained.

The costs are rising.

And employers are desperate for solutions.

The Next Generation of Healing

Across the country, a new model is emerging — one rooted in integrative and evidence-informed care.

Medical cannabis is being explored and integrated into some treatment strategies for conditions once considered difficult to manage, including:

  • Chronic pain
  • Post-traumatic stress disorder (PTSD)
  • Anxiety and depression
  • Neurological conditions
  • Sleep disorders
  • Substance use disorder recovery support

Outcomes vary by patient, condition, and clinical oversight, but for many patients, cannabis may serve as replacement or adjunct therapy in certain cases, potentially reducing reliance on pharmaceuticals such as:

  • Opioid pain medications
  • Anti-convulsants
  • Antidepressants
  • Sleep medications
  • Topical steroid treatments

This approach is often referred to as Cannabis Replacement Therapy — and its implications for healthcare economics are profound.

A Proven Model in Action

CannaCoverage Insurance Services, a national cannabis-focused insurance brokerage and consulting firm based in New Jersey, has been working with public-sector partners to bring medical cannabis access into employer-sponsored benefit strategies.

Through innovative benefit structures that integrate alternative therapeutics into existing group health frameworks, CannaCoverage is helping organizations:

  • Expand access to physician-guided medical cannabis programs
  • Reduce reliance on costly pharmaceutical treatments
  • Improve employee health outcomes
  • Mitigate long-term healthcare spending

This model is already making a measurable impact.

Working with municipal and education partners including Trenton, Teaneck Board of Education, and Orange Board of Education, alternative benefit strategies have begun introducing employees to medical cannabis as part of broader wellness initiatives.

The results are promising:

  • Reduced dependency on prescription pain medications
  • Improved employee productivity
  • Lower healthcare utilization costs

Why the Cannabis Industry Should Care

For cannabis operators across the country, this moment represents more than a public health opportunity — it represents the next phase of industry growth.

If medical cannabis becomes integrated into employer-sponsored benefit strategies, the implications are enormous.

  1. Healthcare Cost Reduction

Studies indicate that states with medical cannabis programs see average annual health insurance premium savings of approximately $1,663 per individual compared to states without such laws.

When cannabis replaces or reduces reliance on high-cost pharmaceuticals, the downstream impact could include:

  • Fewer emergency room visits
  • Lower prescription drug spending
  • Reduced long-term treatment costs
  1. Improved Health Outcomes

Many pharmaceutical treatments introduce side effects that lead to additional prescriptions — creating the familiar “prescription cascade.”

Medical cannabis, when used under physician guidance, can help patients manage symptoms while potentially reducing adverse pharmaceutical side effects.

  1. Safe and Regulated Access

Patients enrolled in medical cannabis programs receive recommendations from licensed medical professionals and access regulated products that meet testing and safety standards.

  1. Workforce Productivity

Healthier employees mean:

  • Reduced absenteeism
  • Lower overtime costs due to call-outs
  • Improved presenteeism and productivity
  1. Community and Economic Impact

Healthier workers create stronger communities.

Reducing chronic pain, addiction risk, and mental health challenges reduces strain on:

  • Emergency services
  • Public health systems
  • Municipal budgets
  1. Expanding the Cannabis Consumer Base

If medical cannabis benefits enter mainstream employer healthcare plans, millions of Americans who have never considered cannabis may begin exploring it as a legitimate medical option.

This introduces entirely new patient populations to the cannabis marketplace — including those managing chronic illness, aging populations, and healthcare professionals themselves.

A Data Opportunity for the Industry

Employer-integrated medical cannabis programs also unlock something the industry desperately needs: Data.

Through benefit programs and structured patient pathways, the industry can begin collecting valuable insights into:

  • Conditions being treated
  • Prescription medications replaced
  • Patient outcomes
  • Cost savings

This data will strengthen research, inform policy decisions, and help solidify cannabis as a credible therapeutic option in modern medicine.

The Public Health Reality

Consider one stark statistic:

Opioid overdose remains the leading cause of accidental death in the United States.

By contrast, according to federal data, there have been zero documented deaths from cannabis overdose.

This reality demands thoughtful discussion about how cannabis may play a role in harm reduction and alternative treatment pathways.

A Call to Lead — Not Follow

The cannabis industry has spent decades fighting for legitimacy.

Now it has the opportunity to prove its value in one of the most important sectors of American life: healthcare.

Cannabis operators, cultivators, manufacturers, dispensaries, researchers, and ancillary businesses must come together to support this next evolution.

The opportunity is clear:

  • Work with insurance innovators
  • Partner with employer groups
  • Collaborate with public administrators
  • Support evidence-based research
  • Advocate for responsible medical access

Together, we can re-imagine healthcare through medical cannabis.

We can reduce healthcare spending.

We can improve patient outcomes.

We can address the opioid crisis through alternative therapeutic pathways.

And we can restore the central promise that launched this industry in the first place:

Helping patients live healthier, safer lives.


Disclaimer: The content in this blog is for informational or educational purposes only and does not substitute professional medical advice or consultations with healthcare professionals.

Member Blog: What Consumers Really Want in a Pre-Roll

The cannabis pre-roll market has exploded into a $3.6 billion per year industry – and still growing. It’s the fastest-growing category in the industry and one of the top add-ons at dispensaries around the country, with 82% of cannabis smokers buying pre-rolls.

That’s why it’s never been more critical for manufacturers to understand what drives consumer choices, particularly in this highly competitive category. 

Custom Cones USA’s comprehensive consumer report, which surveyed over 900 cannabis users and analyzed Headset’s point-of-sale data from across multiple states, helps give a better idea of what today’s pre-roll consumers are looking for in their favorite smokes.

Potency, Price and Brand: The Holy Trinity

When it comes to purchasing decisions, three factors dominate consumer priorities: potency, price and brand. These are the make-or-break elements that determine whether a product flies off dispensary shelves or collects dust. 

It’s one of the reasons infused pre-rolls (which combine flower with a concentrate for a higher potency number) sell so well, and why the top brands all put significant effort into the customization and branding efforts.

However, the market also shows a push and pull between premium and value segments, with successful brands offering products at both ends of the spectrum.

The data reveals a clear premiumization trend, particularly in infused pre-rolls, which now command over 44% of pre-roll market share and tend to deliver the biggest bang for the buck. Consumers are increasingly willing to pay premium prices for premium experiences, with top brands like Jeeter averaging nearly $25 per unit. 

At the same time, value-focused brands are thriving by offering high-volume, low-cost options that appeal to budget-conscious consumers seeking consistent quality. These brands may not have the highest price points, but what they may miss at the register they can make up for in volume.

After price and potency, the top factor for choosing a pre-roll is brand, which is why all five of the top 5 brands in the country use custom branding on their pre-rolls themselves, not just the packaging. 

Without its packaging, every unbranded pre-roll looks basically the same, so how is a consumer supposed to know what to ask for the next time they are at the dispensary? The top brands customize their pre-roll filter tips, either with custom logos printed directly on the filters themselves, custom cigar bands, colorful overwraps that wrap around the filter, or some combination of all of them.

Size Matters: The Full-Gram Preference

But what size pre-roll should you offer? The modern pre-roll market encompasses a wide variety of sizes in both cones and tubes, ranging from the 70mm mini cone that holds about 0.3 grams all the way to full-gram 109mm cones (and even bigger).

Well, consumer preference for pre-roll size is clear: the 1-gram size dominates the US market, generating $1.45 billion in revenue, more than double the amount of second place (2.5 grams). And of those 1-gram products, nearly 82% are single, 1-gram pre-rolls. 

The remaining 18% of 1-gram product sales are multi-packs, which is the real key to unlocking pre-roll sales. 

While only about 49% of all pre-roll products are multi-packs, the format owns the best-selling product charts, accounting for 49 of the top 50 and 91 of the top 100.

In fact, the Headset data shows that nine of the top 10 best-selling products are, specifically, five-packs of half-gram pre-rolls, giving even more insight to just what shoppers are looking for in their pre-roll experience.

Our survey of smokers backed this up, with 56.7% of respondents saying the full-gram is the size they buy most, followed by the half-gram at 28.3%.

Paper Type: More Than Just Wrapping

While it might not rank in the top three purchasing factors, paper type also matters significantly to pre-roll consumers. More than 55% of surveyed users rated paper type as “very important,” while only 9% of those surveyed called it “not important.” 

Though there is no way in the POS data to tell what type of paper is used in the products sold, there are three main types and each play more into branding and messaging than one may think.

Refined white papers, sometimes called “rice papers” in the industry despite being made of wood pulp, remain popular for their clean, tasteless smoking experience. Meanwhile, natural brown papers appeal to consumers seeking a more, well, natural look. There is no difference in taste or burn rate from the whites, but many smokers have a preference. Finally, there is organic hemp, made from hemp pulp instead of wood pulp and are a great option for holistic, environmentally conscious brands. 

But the variety in paper preferences underscores an important truth: today’s pre-roll consumer is sophisticated and discerning, with specific expectations about their smoking experience from start to finish that factor into their purchasing choices.

What Types of Pre-Rolls Are People Buying?

The top segment of pre-roll sales, by far, is the Infused pre-roll, as we already mentioned, accounting for 47.2% of sales in 2025, totaling nearly $1.7 billion. That was followed by Hybrid single-strain at $1.3 billion (37%), Indica single-strain at $238 million (7%), Sativa single-strain at $227 (6%) and Mixed strain at $77.8 million (2%).

However, when we look at the units sold, the top two spots flip, with Hybrid single-strain pre-rolls selling 175.6 million units (46%) compared to 144.6 million (38%) for Infused products.

The difference, of course, comes back to price point. Infused products have a higher price point, generating more revenue on fewer units sold. That said, again looking at the top-selling products, 16 of the top 20, 43 of the top 50 and 80 of the top 100 are infused.

Premium Features Gaining Traction

While traditional pre-rolls remain popular, premium features are gaining significant traction. 

More than 21% of consumers purchase pre-rolls with premium filter tips at least once weekly, indicating openness to enhanced smoking experiences. Premium filter tips, like flavored wood, can enhance any session, while smooth glass and premium ceramic filter tips help cool the smoke for bigger, more flavorful hits.

Premium filter tips are also a great way to help your product stand out and be remembered.

The Bottom Line

Today’s pre-roll consumers want quality, consistency and value, whether they’re purchasing budget-friendly options or premium infused products. They care about potency levels, price, brand and paper quality as part of their decision-making process.

They prefer single-serving, full-gram pre-rolls AND multi-packs that offer variety and convenience. Most importantly, they want products that deliver a superior smoking experience that enhance their lifestyle.

For producers, the message is clear: the pre-roll is here to stay and is a major driver of revenues for the entire industry. It is a category that all serious brands must be a part of if they want to grow and expand.

Member Blog: The Evolving Cannabis Legal & Regulatory Landscape in 2026

What Every Cannabis Operator, Bank, and Entrepreneur Must Understand About Rescheduling Before It Happens

We have all watched this moment build for years. The December 2025 executive order directing movement on cannabis rescheduling felt, to many of us, like the signal we had been waiting for. But between legal practice, business operations, and cannabis banking, we have learned the same lesson repeatedly: signals are not outcomes. The space between an executive order and an effective federal rule is exactly where the most consequential mistakes get made.

What we want to address directly is the gap between what the executive order promises and what it actually delivers. That gap is where operators are making decisions right now, and where the greatest exposure lives. Rescheduling is probable. It is not done. And the path between here and there runs through administrative hearings, proposed rulemaking, and litigation that is already being organized.

An Executive Order Begins a Process. It Does Not Complete One.

From a legal standpoint, the December 2025 executive order initiated the administrative hearing process for moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. That hearing is still pending. No final rulemaking has been issued. Cannabis remains federally illegal today, exactly as it was before the order was signed.

We are already seeing operators and institutions treat this order as resolved policy, and that is a serious misjudgment. Post-hearing litigation is widely anticipated. The most realistic timeline for an effective rule is 2027 at the earliest. Build your compliance architecture, your tax structure, and your banking relationships around the legal environment as it exists. Treat rescheduling as upside, not foundation.

“The executive order initiates a process. Until that process concludes and a final rule is in place, every operator is still in a federally illegal space, and every business decision needs to reflect that reality.”

Rescheduling and Descheduling Are Not the Same Thing.

One distinction every operator must hold clearly is the difference between rescheduling and descheduling. Rescheduling moves cannabis within the Controlled Substances Act. Descheduling removes it entirely. Many in the cannabis community would strongly prefer descheduling, and that preference is well-founded. But what is on the table is rescheduling, and that carries specific legal consequences that operators need to understand now, not after a rule is finalized.

Under a Schedule III framework, operators who obtain DEA registration and comply with FDA oversight would operate within federal law, gaining access to interstate commerce and pharmaceutical-level legitimacy. Those who do not pursue DEA registration, the majority of adult-use and recreational businesses, would remain federally illegal despite holding valid state licenses. For manufacturers in states like New York, where Good Manufacturing Practice certification is already required, the pathway to DEA licensing may be closer than many realize.

Section 280E: The Most Consequential Financial Change With Looming Uncertainty.

Section 280E of the Internal Revenue Code prohibits ordinary business deductions for any entity trafficking in Schedule I or Schedule II substances. A move to Schedule III would, on its face, remove cannabis businesses from that prohibition. The financial impact would be significant, and we have watched operators absorb this burden for years. The prospect of relief is real.

What is also real is the legislative risk. Proposed legislation has already emerged that would keep 280E-style restrictions in place even after rescheduling, requiring separate congressional action to deliver the relief many founders are already projecting. Structure your chart of accounts to preserve optionality. Run parallel planning scenarios under the current regime and assuming relief. Do not commit to a single financial projection until congressional action confirms the outcome.

“Excitement about rescheduling is valid. But structuring your business around it before it is final is a risk most operators and entrepreneurs cannot afford to take. Build for where the law is, and design for where it may go.”

For Banks, the Compliance Burden Has Not Moved.

Rescheduling will not change the compliance obligations that govern cannabis banking. The 2014 FinCEN guidance remains in force regardless of scheduling status. The enhanced onboarding, the ongoing due diligence, the Suspicious Activity Report filings required even in the absence of suspicious activity, the Currency Transaction Reports that multiply rapidly in cash-intensive operations: none of that changes with a scheduling decision.

Institutions entering or expanding in the cannabis banking space should structure their programs around these obligations as standing requirements, not temporary constraints pending rescheduling. What may change over time is institutional appetite, particularly for operators who elect DEA registration and operate within a federal framework. But that is a downstream development, contingent on rulemaking that has not yet begun.

“I built a cannabis banking program from the ground up. The one thing every institution entering this space must understand is that the compliance infrastructure is permanent. Rescheduling does not reduce the filing stack. Plan for that from day one.”

Hemp Is Now the More Urgent Concern.

If rescheduling has generated optimism in parts of the cannabis industry, the appropriations bill provision inserted in November 2025 has done the opposite for hemp. That provision effectively recriminalized significant portions of the infused hemp market, with a one-year grace period. Hemp was the sector many considered safe, protected by the Farm Bill and attractive to banks unwilling to touch cannabis. That stability has been disrupted.

The ripple effects are already being felt across operators, lenders, patients, and supply chains. Hemp businesses and their banking partners should treat this as requiring immediate legal review of product classifications, contract structures, and banking relationships. Waiting for legislative resolution is not a strategy in an environment this fluid.

How to Position Now, Before the Rules Are Final.

For entrepreneurs and operators asking where to focus while rescheduling remains unresolved, our answer is consistent: build positions that are resilient to the ambiguity rather than dependent on its resolution. Ancillary businesses, those not directly touching the cannabis plant, offer lower capital requirements, fewer licensing hurdles, and meaningful insulation from regulatory shifts. Demand for technology, compliance consulting, legal services, and accounting persists regardless of how the federal framework evolves.

For those entering a specific state recreational market, the foundational work is research: understand the licensing framework, assess the existing medical market to gauge total addressable market, build the business model before committing to a license type. Skills developed in hemp cultivation, processing, and GMP practices transfer directly to cannabis operations. The knowledge built on one side of that legal line is fully applicable on the other.

The Bottom Line

We are not pessimistic about rescheduling. We believe it will happen. The political incentives are aligned, the administrative process has been initiated, and the current administration has expressed clear support. What we are realistic about is the timeline and the complexity. An effective rule is unlikely before 2027. Litigation will be contested. And the gap between rescheduling and the full legal clarity this industry ultimately needs remains wide.

The operators and institutions who will be best positioned when the rules finally change are the ones building durable programs today. Legal structures that work under 280E and can adapt if it disappears. Banking relationships built on full compliance, not regulatory optimism. Hemp businesses that have reviewed their exposure and acted. The market will not pause for clarity. Those who prepare for the complexity will be ready when it resolves.

How THCa Vapes Are Changing Consumer

According to industry reports, the cannabis vaporizer market was valued at an estimated $6.6 billion in 2024. By 2035, it is expected to exceed $25 billion, growing at an annual rate of more than 14 percent. These numbers indicate a clear shift. Consumers are moving away from traditional smoking and looking for cleaner, more controlled ways to use cannabis. Vaping has become a preferred option in many legal markets. It is discreet, easy to use, and offers quicker effects compared to edibles. As this format grows, people are paying closer attention to what they consume and how it fits into their daily routines.

Within this space, THCa vapes are gaining steady attention. They offer access to the THC experience through modern devices while, in some jurisdictions, fitting into hemp-friendly legal frameworks. That said, understanding why consumers are turning toward these products helps explain how preferences in legal cannabis markets are changing. Below, we take a closer look at the factors driving this shift.

1. Demand for Discreet, Convenient Consumption

Today’s cannabis consumers are looking for more than just potency. Convenience and discretion now play a major role in how people choose their products. Traditional smoking is increasingly seen as less practical, especially in daily routines, shared spaces, or public settings. Vaping, by comparison, offers a cleaner and more controlled way to consume cannabinoids, with less odor, no combustion, and far less visible activity. Research supports this shift. Consumer research has found that for cannabis vape users, device type and regulated status strongly influenced purchase decisions—often as much as price or potency.

THCa vapes align with this preference change. In particular, full-spectrum THCA disposables appeal to consumers who want a simple, ready-to-use option without extra steps or maintenance. These disposable formats remove the need for:

● Refilling,
● Charging multiple components, or
● Handling loose products.

These features make them more accessible for both experienced users and newcomers. Additionally, reputable brands such as The Hemp Doctor have responded to this demand by offering THCa vape options that prioritize portability, consistency, and ease of use. Long story short, as more consumers move away from flower and traditional edibles, discreet disposable vapes are becoming a practical choice that aligns with modern cannabis lifestyles.

2. Potency and Experience: What Users Are Looking For

Another reason THCa vapes are reshaping preferences is the combination of potency and quick onset of effects. THCa itself is a precursor to THC. When heated in a vape device, it undergoes decarboxylation and converts into active THC compounds that deliver the expected psychoactive experience without the smoke of combusted plant material. This dynamic appeals to consumers for several reasons:

● Fast onset – Vaping absorbs cannabinoids into the bloodstream rapidly through the lungs, often producing effects within minutes, which many users find preferable to edibles.
● Controlled dosage – Users can take small draws to pace their experience rather than ingesting an entire edible dose.
● Consistency – Modern extraction and manufacturing standards ensure that each disposable delivers a repeatable experience.

In a market where consumers are increasingly informed and particular about what they are inhaling or consuming, these experiential benefits can outweigh more traditional forms of cannabis intake.

3. Expanded Legal Access and Market Reach

One of the biggest reasons THCa vapes are gaining attention is their expanded legal reach. Because THCa is commonly derived from hemp that meets federal guidelines, these products can be sold in some markets where traditional THC products are still restricted. In the United States, this has opened access in many states that do not yet have fully established adult-use cannabis programs.

This legal distinction has had a measurable impact on consumer behavior. In fact, some market reports suggest that THCa vapes captured nearly 23% of the hemp-derived cannabinoid market by early 2025, reflecting rapid adoption in a short period of time. This broader access has reshaped who participates in cannabis vaping:

● Consumers in non-recreational states now have legal access to vape products.
● Curious or first-time users can explore cannabis formats with fewer barriers.
● Brands are innovating quickly to meet demand within compliant frameworks.

Rather than replacing traditional THC markets, THCa vapes are expanding the overall consumer base. Their growth suggests that legal accessibility, when paired with modern formats, plays a major role in shaping preferences across evolving cannabis markets.

4. Health Perception and Tech-Driven Preference Shifts

Many consumers view vaping as a lower-risk mode of consumption compared with smoking. Research has observed that vaping cannabis, especially via devices that control temperature and avoid combustion, results in fewer toxic emissions than burning plant material.

This perception—whether accurate in its entirety or nuanced—is reshaping preferences. Health-conscious consumers, in particular, are drawn to products that are:

● Less irritating to the lungs, due to vapor rather than smoke.
● Easier to integrate into lifestyles that prioritize wellness or discretion.

Technology also plays a role. Innovations in device heating elements, battery life, and vapor quality have made vape products more consistent and reliable. Users now expect smooth performance, consistent potency, and a pleasant user experience—factors that significantly influence purchase decisions.

This tech-centric trend is reflected in broader industry growth. The global cannabis vaporizer market is projected to expand significantly, more than doubling in size from 2024 to 2030, as consumers increasingly prefer portable, technology-enabled formats.

Final Thoughts

The rise of THCa vapes in legal cannabis markets is far more than a fad. It reflects fundamental shifts in how consumers think about cannabis—prioritizing convenience, discretion, predictable effects, and a regulated experience. With the vaporizer market projected to expand dramatically in the coming decade, these preferences are setting the stage for new product categories and consumption norms.

Whether for seasoned cannabis users or newcomers exploring smoke-free options, THCa vapes are undeniably reshaping preferences in regulated markets and helping define the future of cannabis consumption.

Announcing NCIA’s 2026-2028 Board of Directors

The National Cannabis Industry Association (NCIA) is pleased to introduce the leaders elected to serve on its Board of Directors for the 2026–2028 term. Drawn from across the regulated cannabis marketplace, this group reflects the breadth of today’s industry and a shared commitment to responsible growth, sound policy, and long-term sustainability.

New Members Joining the Board

Directors Reappointed to Continue Their Service

Through NCIA’s member-informed nomination process — led by the Annual Nominating Committee and supported by board leadership — the following directors have been selected to serve an additional term:

This process is designed to ensure the Board reflects the evolving needs, expertise, and perspectives of the legal cannabis community.

Leadership at a Turning Point for the Industry

Both NCIA and the broader cannabis marketplace are entering a consequential period. Federal policy discussions are accelerating, regulatory approaches across marijuana and hemp are increasingly intersecting, and the national cannabinoid economy continues to expand in complexity and scale.

At moments like this, industry alignment and credible leadership are essential. NCIA’s Board of Directors plays a critical role in helping the association convene stakeholders, advocate for workable regulatory frameworks, and support operators navigating a rapidly shifting environment.

Directors serve staggered two-year terms, balancing continuity in governance with the introduction of new ideas and leadership.

The incoming and returning members will serve alongside directors currently in the 2024–2026 term:

Together, this leadership team positions NCIA to strengthen its role as a national advocate and a forum for collaboration across the cannabis ecosystem.

Board Officers and Policy Leadership

The Board has also confirmed its officer slate for the upcoming term:

  • Chair: Adam Rosenberg (re-elected)
  • Vice Chair: Amy Larson
  • Treasurer: Naomi Granger (re-elected)
  • Secretary: Jordan Isenstadt
  • At-Large Executive Committee Officer: Adam Stettner

These officers will form the Executive Committee responsible for supporting governance and strategic oversight.

After completing two terms as a director, Michael Cooper will transition off the Board and has been selected to serve as Policy Chair, continuing his work advancing NCIA’s advocacy priorities and policy engagement.

Looking Ahead

NCIA’s mission remains focused on supporting a safe, equitable, and economically vibrant cannabis industry. The 2026–2028 Board brings together experienced leadership and new perspectives at a time when thoughtful coordination and active engagement will shape the industry’s next phase.

To learn more about NCIA’s Board of Directors and view member biographies, please visit our Board Members Page.

NCIA remains at the forefront of championing the cannabis industry’s growth and prosperity. The 2026-28 board is poised to lead with vision and dedication, ensuring that NCIA continues to be a driving force in shaping the future of cannabis.

With this new Board in place, NCIA is positioned to continue advancing policies, partnerships, and industry collaboration that support legitimacy, stability, and opportunity across the legal cannabis market.

Rooted in Community: Vlasic Labs

At the foundation of NCIA is a vibrant community of innovators, advocates, and industry leaders united by a shared commitment to advancing a fair, inclusive, and sustainable cannabis industry. Our Rooted in Community series celebrates the members who bring that mission to life through their work and leadership. This month, we’re honored to highlight Evergreen Member Vlasic Labs.


NCIA: Can you walk us through the products and services Vlasic offers and the customers you’re focused on supporting?

Vlasic Labs:  CBD CBG and CBN Topicals, Tinctures, Gummies and Pet products for anyone looking to improve their lives through affordable natural wellness. 

NCIA:  What sets your company apart from others in your market?

VL:  The Vlasic brand brings a level of comfort and trust for customers that are new to CBD or cannabis. For long-time customers of the space, they recognize the value per milligram they are getting when they purchase Vlasic. Being able to resonate with the masses in an industry that still deals with the stigma of the past is our superpower.

NCIA: In what ways has your company evolved over time in terms of strategy, offerings, or market focus?

VL:  Our company has evolved multiple times and will continue to do so as this industry changes and our customers provide feedback. Right before COVID, we started as a hemp extraction lab and our original differentiator was being one of the first labs to convert CBD into CBN. This led us to launch our first finished product, a CBN Sleep Spray. The initial success of this product led to expansion of more SKUs and eventually partnering with grows to launch Vlasic Flower as well. On the flower side, we entered and exited the Michigan market within a couple of years and now are focused on Missouri and Nevada. We hope to continue growing our national presence on the CBD side, while strategically selecting which states make the most sense for further flower expansion. 

NCIA:  What inspired your decision to join the NCIA community, and what value do you see in being part of the organization?

VL: We joined NCIA to stay actively involved in policy decisions and the network of industry leaders shaping the future of cannabis access. Our mission to make cannabis-based wellness more affordable and trusted depends on strong industry standards, smart regulation, and collaboration with others committed to long-term progress. NCIA provides that connection and helps us operate with clarity and purpose in a fast-moving environment.

NCIA: Can you share an example of a meaningful relationship you’ve built through your NCIA membership?

VL: At NCIA Lobby Days, we met Mariah James Bond, founder of the Montana Cannabis Coalition. That relationship gave us the access, insight, and local support needed to enter the Montana market. Without that introduction, we would not have had a path into the state.

NCIA:  What NCIA moment stands out to you most?

VL: One of our most meaningful NCIA moments was in 2018 when our partner Adam Rosenberg attended his first Lobby Days in Washington, D.C. He met directly with lawmakers, worked alongside other industry leaders, and saw the importance of coordinated advocacy firsthand. That experience was a turning point in his career, and he now serves as Chairman of the Board.


Vlasic Labs demonstrates how transformative it can be when community is placed at the heart of leadership.  Beyond delivering thoughtful, customer-first service, they actively champion the future of the cannabis industry through advocacy and leadership. As longtime NCIA members, and through Board Chairman Adam Rosenberg’s leadership, they continue to help shape critical conversations around equity, access, and reform. We’re grateful for the meaningful impact Vlasic Labs is making to move the industry forward.

Together with our members, NCIA is building a stronger, more equitable cannabis industry. One rooted in community and driven by shared purpose. Join the community. Join NCIA.

Announcing Winners of NCIA’s State Regulatory Committee 2025 CannaStar Awards

The National Cannabis Industry Association’s State Regulatory Committee announces the 2025 CannaStar Award winners, recognizing states and leaders for meaningful progress in cannabis regulation and program implementation across the United States.

State-level cannabis regulation remains a moving target or more accurately, 50 moving targets. While nearly every state now operates some form of regulated medical or adult-use cannabis program, each continues to navigate its own policy constraints, enforcement realities, and market pressures.

Entering 2026, the National Cannabis Industry Association’s State Regulatory Committee (NCIA SRC) is recognizing jurisdictions that moved beyond framework-building and delivered practical outcomes—whether through equitable license issuance, clear youth protections, effective responses to federal conflict, or thoughtful stabilization of mature markets.

By highlighting both expected and unexpected successes, the Committee aims to support cross-jurisdiction learning, reduce unnecessary regulatory friction for operators, and advance cannabis systems that function in practice for regulators, businesses, and consumers alike.

Without further ado, here are the 2025 NCIA State Regulatory Committee CannaStar Award winners.


Best Social Equity Program: New York 

New York earns the 2025 CannaStar for Best Social Equity Program based on one critical metric: licenses are actually being issued, and at a meaningful scale.

New York’s Social and Economic Equity (SEE) framework has produced tangible outcomes, with equity applicants receiving a majority share of adult-use licenses and a growing number of equity-owned dispensaries operating statewide. Unlike many programs that stall at scoring or conditional approval stages, New York’s equity licensees are increasingly transitioning into active businesses, creating real-world case studies for other states to examine.

The Committee acknowledges that New York’s rollout has not been without challenges. Early conditional cultivators and farmers experienced delays and uncertainty that slowed parts of the supply chain for several years. Even so, New York’s willingness to course-correct and its demonstrated ability to move equity applicants into the marketplace distinguish it from peer programs that remain largely aspirational.


Best Regulator: Maryland 

Maryland earns the 2025 CannaStar for Best Regulator for prioritizing experienced, outcomes-driven leadership during a critical market expansion phase. Maryland stands out in 2025 for its leadership transition to a regulator with proven experience managing complex cannabis market rollouts at scale.

With the appointment of Tabitha Robinson as Director of the Maryland Cannabis Administration, the state signaled a clear commitment to professionalized, outcomes-driven cannabis regulation at a pivotal moment for its adult-use market. Maryland’s program is rapidly maturing, with strong early sales performance and one of the most ambitious equity-focused licensing efforts in the country.

Robinson brings direct institutional knowledge from her prior leadership roles at the New York State Office of Cannabis Management, where she helped operationalize one of the nation’s largest social equity licensing frameworks. Her experience navigating high-volume licensing, equity verification, and market stabilization in New York positions her uniquely to guide Maryland through its next phase of growth while avoiding many of the pitfalls seen in earlier state rollouts.

The Committee views Maryland’s selection of an experienced, equity-literate regulator as a strong example of how states can accelerate program maturity by investing in leadership with proven, transferable regulatory expertise.


Best Protection for Minors: Missouri

Missouri earns the 2025 CannaStar for Best Protection for Minors for establishing clear, enforceable safeguards in the intoxicating hemp-derived cannabinoid market. Missouri stands out in 2025 for taking a clear, enforceable approach to youth protections in the rapidly evolving hemp-derived cannabinoid market.

As intoxicating hemp-derived products (including delta-8 and other THC analogs) proliferated nationally, Missouri moved to close a common regulatory gap by advancing age-gating and consumer protection requirements that mirror adult-use cannabis safeguards. Missouri’s approach focuses on preventing youth access without relying on vague guidance or inconsistent local enforcement, instead establishing clear age thresholds and compliance expectations for retailers.

Rather than treating hemp-derived intoxicants as an entirely separate consumer product category, Missouri’s framework acknowledges their functional similarity to regulated cannabis products and applies proportionate protections accordingly. This clarity benefits regulators, retailers, and law enforcement alike, while reducing the likelihood of youth exposure through loosely regulated channels.

The Committee views Missouri’s actions as a practical model for states seeking to protect minors without overcorrecting in ways that destabilize lawful hemp businesses or create enforcement ambiguity.


Best Challenge to the Feds: Texas

Texas earns the 2025 CannaStar for Best Challenge to the Feds for advancing a constitutional case that directly confronts federal cannabis prohibition’s conflict with state law. Texas stands out in 2025 for producing the most consequential constitutional challenge to federal cannabis prohibition to date, one that directly tests how federal law treats state-legal cannabis consumers.

A Texas-raised case has challenged the federal prohibition on firearm possession by “unlawful users” of controlled substances under 18 U.S.C. § 922(g)(3), arguing that the statute cannot constitutionally be applied to individuals who lawfully use cannabis under state law. The challenge builds on recent Supreme Court Second Amendment jurisprudence and exposes a core tension between federal prohibition and state-regulated cannabis markets. That case, United States v. Hemani, will be heard by the Supreme Court of the United States on March 2.

While the Supreme Court has not yet issued a final ruling resolving this conflict, Hemani places cannabis squarely within the broader constitutional debate over federal overreach and individual liberties, moving the issue beyond administrative reform and into the highest-stakes legal arena.

The Committee views this category as recognizing not just litigation success, but strategic legal pressure that forces federal cannabis policy contradictions into the open. Although the Second Amendment context did not originate as a cannabis reform effort, it has become one of the most direct vehicles for challenging the federal government’s continued treatment of cannabis consumers as criminals despite widespread state legalization.


Best Tax Rate Reform: California 

California earns the 2025 CannaStar for Best Tax Rate Reform for taking a corrective step that stabilized its legal cannabis market through coordinated advocacy and legislative action. 

In 2025, California took an important corrective step to stabilize its legal cannabis market by rolling back a scheduled increase to the state excise tax, an outcome made possible by sustained, coordinated advocacy from cannabis businesses across the state. After years of mounting pressure on licensed operators, the cannabis industry banded together and lobbied aggressively to reverse an excise tax hike that would have further widened the price gap between the legal and illicit markets. The increase had raised the cannabis excise tax from 15% to 19% effective July 1, 2025. On September 22, 2025, Governor Gavin Newsom signed Assembly Bill (AB) 564, which rolled back that increase and restored greater predictability to the tax structure. The 15% rate is locked in through June 30, 2028.

By maintaining the excise tax at a fixed rate rather than allowing it to escalate automatically, California acknowledged the real-world impact of cumulative taxation on licensed businesses. While the change did not resolve the state’s broader tax burden or eliminate structural challenges facing operators, it provided immediate and meaningful relief at a critical moment. Businesses gained greater certainty in forecasting costs, improved ability to price products competitively, and increased capacity to remain compliant in an already challenging operating environment.

The Committee views California’s action as an important example of what can be accomplished when cannabis businesses work together toward a shared policy goal. Rolling back the increase was not an expansion of the market, but it was a necessary recalibration—one that helped prevent further erosion of the legal cannabis industry and demonstrated the power of collective, unified advocacy.


Best Medical Cannabis Program Preservation: Utah

Utah earns the 2025 CannaStar for Best Medical Cannabis Program Preservation for maintaining a deliberately patient-centered medical cannabis program that has remained insulated from adult-use pressure and excessive taxation. Since its inception, Utah has treated medical cannabis as a regulated healthcare access system, not a transitional retail market.

Utah’s medical cannabis program is structured to limit tax exposure for patients. Medical cannabis purchases are exempt from Utah’s state sales tax, and the state has not imposed any retail-level excise tax on medical cannabis patients. Instead, Utah relies on fixed licensing fees and regulatory assessments applied to operators, rather than percentage-based excise or gross receipts taxes tied to transaction value. This fee-based approach avoids the compounding tax effects seen in other states where medical programs become revenue-generating mechanisms rather than patient services.

Because Utah does not levy a point-of-sale excise tax or gross receipts tax on medical cannabis, patients are shielded from price inflation driven by tax stacking. This structure is particularly significant given Utah’s narrow qualifying conditions, limited product formats, and physician-driven access model, where patients are already navigating higher barriers to entry than in many medical states.

By maintaining a low-tax, fee-based regulatory structure, Utah has preserved relative pricing stability for patients relying on cannabis to manage chronic pain, PTSD, neurological disorders, and terminal illnesses. Operators are likewise able to plan within a predictable cost framework without passing fluctuating tax burdens downstream to patients.

Beyond tax policy, Utah has exercised notable regulatory restraint. The state has avoided abrupt program changes, resisted commercial expansion pressures, and continued to administer the program through a public health lens rather than an adult-use-adjacent marketplace. In the absence of any adult-use legalization pathway, Utah’s consistency has prevented the erosion of medical access that often occurs when programs are overshadowed by broader consumer markets.

The Committee views Utah’s approach as a clear example of medical cannabis preservation through intentional design. By exempting medical cannabis from sales tax, declining to impose retail excise or gross receipts taxes, and relying instead on fixed regulatory fees, Utah has protected the medical program’s core purpose while ensuring long-term stability for both patients and licensed operators.


Best Cannabis Legislator: Jeremy Cooney

Senator Jeremy Cooney earns the 2025 CannaStar for Best Cannabis Legislator for his sustained, hands-on leadership in refining New York’s cannabis framework beyond initial legalization.

Throughout the 2025 legislative cycle, Senator Cooney played a central role in refining licensing structures, addressing persistent gaps in the medical cannabis program, and clarifying statutory authority to support functional adult-use retail operations. His work reflects a clear understanding that legalization is not a finish line, but the beginning of an ongoing process requiring legislative maintenance, course correction, and responsiveness to real-world implementation challenges.

Rather than treating cannabis policy as a one-time political achievement, Senator Cooney has consistently focused on making the program workable for regulators, compliant for operators, and credible for communities. His engagement with state agencies, licensees, and patient advocates demonstrates a commitment to translating legislative intent into administrable law.

The Committee recognizes Senator Cooney for exemplifying the kind of legislative stewardship cannabis programs need to succeed long-term: attentive, iterative, and grounded in operational reality.


Best Hemp Legislator: Morgan Griffith

Representative Morgan Griffith earns the 2025 CannaStar for Best Hemp Legislator for advancing comprehensive federal legislation to bring clarity and consistency to hemp regulation.

In 2025, Rep. Griffith introduced an extensive hemp reform bill aimed at addressing regulatory fragmentation that has plagued the hemp-derived products market since passage of the 2018 Farm Bill. The legislation acknowledges that years of ambiguous federal guidance have left states, businesses, and consumers navigating conflicting standards around product safety, THC thresholds, enforcement authority, and interstate commerce.

Rather than pursuing prohibition-by-confusion, Rep. Griffith’s approach recognizes hemp as a legitimate agricultural and consumer products sector that requires clear federal rules to function responsibly. The proposal seeks to establish more consistent definitions, guardrails, and enforcement mechanisms, providing states and regulators with tools to protect public safety without dismantling lawful hemp markets.

The Committee recognizes Rep. Griffith for advancing a serious, substantive effort to bring coherence to hemp regulation at the federal level, and for engaging with the realities of a rapidly evolving marketplace that can no longer be governed by regulatory silence.

Rooted in Community: FundCanna

A stable and equitable cannabis industry depends on access to smart, reliable financial solutions. At NCIA, our network includes financial innovators who help businesses grow responsibly and sustainably. Through our “Rooted in Community” series, we highlight the members driving that progress. This month, we’re proud to spotlight Evergreen Member and NCIA Board Member Adam Stettner, CEO and Founder of FundCanna –  the leading source of capital for the cannabis industry nationwide. 


NCIA:  What financial solutions does FundCanna provide, and which segments of the cannabis industry benefit most from your services?

Adam Stettner:  FundCanna provides short-term, non-dilutive financing to licensed cannabis businesses, including cultivators, manufacturers, distributors, retailers, and ancillary providers. We help operators manage cash flow, move faster, and grow sustainably without giving up ownership.

In 2025, we expanded that mission with ReadyPaid, the first embedded B2B Buy Now, Pay Later (BNPL) solution built specifically for the cannabis supply chain. ReadyPaid gives sellers immediate payment and buyers flexible terms, addressing one of the industry’s biggest challenges — delinquent receivables — while FundCanna’s broader financing solutions work to fuel growth, stabilize cash flow and keep capital moving throughout the legal market.

NCIA:  How is the cannabis industry evolving in your state, and are there any state bills or policy priorities where NCIA members’ support could make a meaningful impact?

AS:  We work nationally and have funded clients in 43 states, so they all matter. Our home state is California, where the legal cannabis market is mature and consolidating. Many smaller operators are finding it harder to compete under high tax burdens, rising compliance costs, and persistent pressure from illicit operators. While demand remains, the regulated market has to work harder to stay viable.

A recent win came with AB 564, which resets the state’s excise tax to 15% (from 19%) through 2028, giving licensed businesses a bit more breathing room.

If NCIA members support measures that reduce unnecessary tax pressure, bring regulatory clarity, and level the playing field with illicit channels, that strengthens the entire ecosystem from operators to service providers like us.

Personally, I believe the entire plant deserves a fair and legal framework.

NCIA:  What motivated FundCanna to join NCIA, and how does the organization’s mission align with your own?

AS:  Advocacy plays a vital role in shaping policy in ways that individual companies simply cannot and we understand that collective representation is essential for creating systemic, long-term change.

FundCanna joined NCIA to help strengthen the financial foundation of the cannabis industry. For me, it’s about listening to the needs of the community and advancing fair access to capital and responsible growth for legitimate operators.

We joined to do the work, not just talk about it. We actively support NCIA’s mission through advocacy, education, and by helping more cannabis businesses take part in those same conversations. Through that effort, we’ve sponsored more than 100 operators to join NCIA, ensuring the people driving this industry forward also have a voice in shaping its future. 

NCIA:  How does NCIA membership contribute to FundCanna’s mission and long-term vision for the industry?

AS:  NCIA allows FundCanna to actively support and help shape the future of the cannabis industry by learning, networking and advancing reasonable regulations and laws. For us, it’s an opportunity to stay close to the issues that matter most to our clients and to contribute where we can add value.

Membership also keeps us grounded. It’s a reminder that progress in cannabis depends on collective effort and that the best ideas often come directly from the operators living it every day.

NCIA:  Tell us about a relationship NCIA membership has helped you build?

AS:  NCIA has helped us build meaningful relationships across the supply chain. We’ve connected with operators, advocacy groups, and policymakers who share a commitment to building a stronger, more sustainable industry. Some of those connections have become long-term partnerships, both through the businesses we fund and the organizations we support.

It’s a reminder that progress in cannabis doesn’t happen in isolation. The more we collaborate, the better this industry becomes for everyone involved.

I value my fellow board members greatly. They’re smart, innovative and dedicated to viable business practices for cannabis.

NCIA:  From a customer’s perspective, what makes FundCanna stand out from competitors?

AS:  FundCanna exclusively serves the cannabis and hemp industries. We understand how operators run their businesses and the challenges that come with managing cash flow. Unlike traditional lenders or investors, we move quickly and only focus on debt and factoring.

We bring more than 20 years and nearly $20 billion of funding/lending experience in consumer and commercial lending. Our focus is partnership over transactions, offering ongoing support and transparency to help clients grow sustainably in a challenging, evolving market. On average, clients who work with us grow their businesses by more than 70 percent.

I often say we’re like the ultimate business partner. We provide the funding with no ownership. We don’t tell you what to do, but we are always available to support growth and smoothing cash flow.

NCIA:  What is a favorite memory you associate with the NCIA community?

AS:  Lobby Days in D.C., easy!

NCIA:  What have been the most significant changes or milestones in your company’s journey since it began?

AS:  We launched FundCanna in 2021 to solve one problem: access to capital for licensed cannabis operators. The goal was simple: give this industry the same kind of financial tools every other industry  takes for granted. In just a few years, we have reviewed nearly 6,000 applications, approved nearly $500 million, and funded almost $250 million to operators across the country.

What began as a straightforward funding platform has grown into a financial infrastructure company for the cannabis economy. We have built technology that delivers faster underwriting and real-time funding decisions. In 2025, we’ve expanded that innovation with ReadyPaid, a Buy Now, Pay Later program that brings predictability and transparency to how businesses pay and get paid, solving the delinquent and disjointed account receivable issue.

Today, FundCanna is not just filling a gap. It is helping define what financial access in this industry should look like. We continue to invest in technology, data, and partnerships that strengthen liquidity, trust, and stability across the legal market.


Dedicated members like FundCanna are the backbone of NCIA’s community. United by a shared belief in the future of cannabis, we’re building an industry that will stand as a vital force in the national economy.  One that is fairly taxed, responsibly regulated, and accessible to the patients who need it most. Thank you, FundCanna, for being truly Rooted in the Community!

Alongside our members, NCIA is building a stronger cannabis industry driven by shared purpose. Join the community, join NCIA.

Member Blog: The EHS Risks Cannabis Processors Don’t See—Until Something Goes Wrong

Cannabis processors have made real progress on environmental, health, and safety (EHS) over the past decade. Compared to the early years of the industry, today’s facilities are more professional, better equipped, and far more aware of regulatory requirements.

Yet serious incidents still occur—fires, electrical events, equipment failures, and high-potential near-misses—often at facilities that appear compliant on paper.

Regulators have observed the same pattern. In 2024, OSHA issued a cannabis-focused enforcement directive noting that multiple accident investigations—including fatalities—have occurred in the industry, with several involving fires and explosions during extraction and other flammable-liquid handling activities.

The takeaway is not that cannabis processing is inherently unsafe. It’s that many of the most consequential EHS risks are latent—they remain invisible during routine inspections and only emerge when operational conditions align in the wrong way.

Compliance Is a Baseline—Not a Measure of Readiness

Most cannabis processors understandably focus EHS efforts on meeting regulatory requirements and passing inspections. That baseline matters.

But compliance systems are designed to answer a narrow question: “Are we meeting the rule?”

Risk management asks a different one: “Where are we most likely to fail, and what would the impact be?”

OSHA investigation records show how this gap plays out. In one documented incident, a worker reported smelling propane and seeing a spark immediately before an explosion that caused second- and third-degree burns. The facility was operating normally—until it wasn’t.

Events like this are rarely caused by a single missing document or training record. They result from a gradual disconnect between written expectations and real-world operating conditions.

Where Latent EHS Risk Commonly Builds in Cannabis Processing

Across the industry, several recurring patterns appear when serious incidents or near-misses are examined.

  1. Change That Outpaces Risk Review

New equipment, higher throughput, modified processes, or repurposed rooms are often implemented quickly to meet demand. Formal hazard reviews frequently lag behind.

Even modest changes—different solvents, increased electrical loads, altered airflow, or new maintenance activities—can materially change risk profiles. When change outpaces evaluation, risk accumulates quietly.

  1. Electrical and Energy Hazards That Don’t Look Dangerous—Until They Are

Cannabis processing environments are energy-intensive, yet electrical and energy hazards often receive less attention than chemical risks.

OSHA inspection narratives include cases where employees performed work on pressurized extraction equipment that had not been fully isolated or depressurized, exposing workers to high-energy release hazards during non-routine tasks.

State programs reinforce that this is not an isolated concern. Washington’s labor and industries agency identifies common cannabis hazards that include pressurized systems, unsafe electrical installations, machine guarding deficiencies, and confined spaces—many unrelated to chemical exposure.

These conditions may not trigger immediate citations, but they significantly increase the severity of failure when something goes wrong.

  1. Risk Outside Core Production Activities

Some of the most serious incidents occur outside primary processing operations.

OSHA records document explosion and flash-fire events during marijuana waste handling, including incinerator backfires during plant material disposal. These activities often receive less scrutiny, even though they involve ignition sources, combustible materials, and non-routine work.

Risk does not stop at the extraction room door.

  1. Contractors and Non-Routine Work

Equipment installation, maintenance, utilities work, and repairs frequently involve contractors who may not fully understand site-specific hazards—or who may rely on assumptions that no longer match current conditions.

Across industries, high-severity incidents disproportionately occur during non-routine tasks rather than day-to-day operations. Cannabis processing follows the same pattern.

From “Safe Enough” to Risk-Informed Operations

Managing EHS risk in cannabis processing does not require excessive bureaucracy or check-the-box programs.

It requires a shift in perspective:

  • from “Are we compliant?”
  • to “Where are we vulnerable?”

Risk-informed operations consistently:

  • review operational changes before implementation
  • look for informal workarounds that have become normalized
  • treat near-misses as early warning signals, not inconveniences
  • engage frontline employees in identifying where work feels uncertain or improvised

The objective isn’t perfection. It’s visibility—seeing risk early enough to make deliberate, informed decisions.

Final Thought

The cannabis industry has matured rapidly, but operational risk often lags behind growth. Regulators, insurers, and fire authorities have documented incidents where hazards were present long before consequences appeared.

Facilities that perform best over time are not those with the thickest binders. They are the ones willing to ask a harder question:

“What risks have become so familiar that we no longer see them?”

Because in cannabis processing, the most serious EHS risks are rarely the obvious ones.

For cannabis processors, improving EHS performance often begins with better risk visibility—not new rules or thicker binders. Periodically stepping back to examine how work is actually performed, how change is managed, and where assumptions may no longer hold can surface risks long before they become incidents.

At Rubicon EHS, this risk-based perspective is grounded in understanding how operations function in practice—not just how they are documented—helping organizations identify and prioritize the EHS risks that matter most as the industry continues to mature.

Plan Your Visit to DC and Be In The Room Where It Happens

As someone who has been a cannabis lobbyist for more than a decade, I’m pretty willing to bet that you’ve said at least one of these things aloud (or to yourself!) at some point:

  • I can’t believe Congress didn’t pass SAFE Banking!
  • What’s wrong with those people in D.C.? Why don’t they understand topic/issue/concept?
  • What’s taking policymakers so long?!

If that sounds familiar and you’re ready to take your expertise to the halls of Congress, keep reading about how you can do just that.

NCIA’s 14th Annual Cannabis Industry Lobby Days | May 12-14, 2026

NCIA is heading back to Washington, D.C. May 12-14 for the 14th Annual Cannabis Industry Lobby Days, kicking off with the National Stakeholder Summit. This year’s program arrives at a pivotal moment for our industry, and for federal cannabis policy writ large.

It’s a midterm election year, cannabis rescheduling is on the horizon, and control of Congress could potentially shift, so the stakes could not be higher.

Midterm elections fundamentally shape the legislative landscape. Committee leadership, party control, and legislative priorities can all change in a matter of months. For the cannabis industry, this uncertainty underscores the importance of engaging policymakers now – before election pressures intensify and policy windows close. 

Lobby days attendees will receive talking points, pre-event training, be placed on a team, and be provided with a pre-set meeting schedule. Lobby days also provides NCIA members with the unique opportunity to meet directly with congressional staff (and maybe even lawmakers themselves!) while decisions are still being formed, not after the fact.

At the same time, the industry stands on the brink of historic change. Indeed, rescheduling has the potential to reshape tax policy, research barriers, medical access, and business operations across the country, but rescheduling alone will not solve all of the industry’s challenges. Policymakers need to understand what comes next: how federal agencies should implement changes, where Congress must act to provide clarity, and how to avoid unintended consequences for state-legal operators, patients, and consumers.

Advocacy is especially critical at this moment because decisions are not being made in a vacuum. Opponents of reform are actively lobbying to slow progress, attach harmful provisions to must-pass legislation, and frame cannabis through outdated and inaccurate narratives. If industry voices are absent, those perspectives risk filling the void.

Showing up in Washington sends a clear message: the cannabis industry is organized, informed, and committed to responsible federal policy. It highlights our collective power: yes, individual meetings matter, but coordinated advocacy that’s grounded in shared priorities and consistent messaging is what drives lasting change. By coming together under the NCIA banner, members amplify their impact and reinforce the association’s role as the leading voice for the regulated cannabis industry. Lawmakers take note when they hear aligned messages from businesses, operators, and advocates across the country.

Make Plans to Join Us

Right now is one of those unique moments where showing up really matters. I want to personally encourage you to register for Lobby Days, start thinking through travel plans (those flights are only going to go up in cost!), and carve out the time to join your fellow members in D.C. Being in the room, telling your personal story, and advocating together makes a real, tangible difference. More details are coming soon, including meeting logistics and preparation tips to help you make the most of your time in Washington. I’ll see you in D.C. in May!

NCIA’s Statement on Decision to Reclassify Cannabis as a Schedule III Substance

The National Cannabis Industry Association (NCIA) welcomes President Trump’s decision to officially direct the Attorney General to reclassify cannabis as a Schedule III substance. Medical professionals, patients, and millions of Americans have long understood that cannabis has accepted medical use and does not belong in the same category as the most dangerous controlled substances. By taking this step, the Administration is recognizing the realities of today’s regulated markets and the work states have done to responsibly oversee them.

NCIA was honored to participate in the Drug Enforcement Administration’s public hearings on rescheduling earlier this year, where we emphasized the importance of supporting state-licensed cannabis programs and the small businesses that form the backbone of this industry which employs hundreds of thousands of workers and contributes billions of dollars to the economy. Moving cannabis to Schedule III will finally lift the crushing burden of §280E, allowing operators to reinvest in their employees, strengthen compliance, and allow them to continue delivering safe, regulated products to consumers. This change acknowledges something that researchers, advocates, and patients have known for years: that the cannabis plant has medicinal value.

This is meaningful progress, but it cannot be the final word. NCIA urges lawmakers to build on today’s decision by establishing a framework that respects states’ rights, supports responsible operators, and provides  clear federal enforcement guidelines in order to provide certainty to the thousands of businesses operating openly and in compliance with state law. NCIA will continue working to ensure that this industry can thrive under policies that are fair, consistent, and reflective of modern realities.

Donate Today

As we close out the year, NCIA invites you to contribute to our advocacy. Year-end donations directly strengthen our federal presence and ensure operators’ voices remain at the center of the conversation. Make a donation here.

Members, thank you for standing with us.

Non-members, now is the moment to join and add your voice. Join online today or schedule a call with our team to discuss membership. 

Together, we move the industry forward.

The MJBiz Breakdown: NCIA Members Share Expertise and Experience

As the industry heads into the biggest conference of the year, make sure your MJBizCon schedule includes the NCIA community, including our advocates, leaders, and members who are driving the future of cannabis. This year’s event brings together innovators across cannabis, hemp, psychedelics, finance, compliance, retail technology, and emerging global markets. Below is your streamlined, chronological guide to every NCIA member-powered session you’ll want on your calendar. And if you haven’t already registered, claim 15% off with our promo code PRT77.


Tuesday, December 2

9:50 – 10:30 AM – Launching Legally: Licensing, Compliance, and Capital for Cannabis Startups
Chelsea Haskins & Angelica Sanchez (Perfect Union), Justin Pilgrim (KeyPoint Credit Union), and Thomas Andersen (CannabisCPA.Tax) break down the essentials for launching a compliant, well-funded cannabis startup.

10:35 – 11:15 AM – Understanding the 2025 Cannabis Consumer – Who’s Buying & Why?
Liz Stahura (BDSA) reveals the evolving motivations and demographics driving next year’s cannabis demand.

11:20 AM – 12:00 PM – Continuing Credit Stress: Restructuring Debt in a Post-280E World
Jeffrey Schultz (Foley Hoag) and Frank Colombo (Viridian Capital Advisors) explore how operators can navigate debt restructuring as tax landscapes shift.

2:30 – 5:30 PM – Associations Day
Brooke Gilbert & Michelle Rutter Friberg (NCIA) will be available to discuss why membership is so important during this critical time for our industry.

2:30 – 3:10 PM – The Cannabis Startup Guide to HR, Payroll & Accounting Success
Raymond Guns, CPA (Dope CFO) highlights foundational financial and HR systems every cannabis startup must master.

3:15 – 4:00 PM – How Will Industry Consolidation Happen with Hemp and Cannabis?
Frank Colombo (Viridian Capital Advisors) discusses the forces shaping mergers and acquisitions across hemp and cannabis.

3:15 – 4:00 PM – When Will Cannabis Brands Finally Get Holiday Marketing Right?
Katie Mattox (Spherex) shares why brands struggle seasonally and how they can finally win the holidays.


Wednesday, December 3

2:00 – 2:40 PM – Bridging the Marijuana and Hemp Divide
Adam Rosenberg (Vlasic Labs), Eric Berlin (Dentons), and Michelle Rutter Friberg (NCIA) explain how the two sectors are finding a unified voice.

2:50 – 3:30 PM – Indigenous Cannabis: Sovereignty, Regulation & Economic Opportunity
Andrew Livingston (Vicente) examines how Indigenous nations are shaping cannabis regulation and commerce.

2:50 – 3:30 PM – Next-Gen Infusions: Innovation, Compliance & the Future of Cannabis Beverages
Diana Eberlien & Harold Han (Vertosa) explore breakthroughs in beverage science and regulation.

2:50 – 3:30 PM – Global Cannabis Outlook: Trends, Policy Shifts & Market Opportunities
Jamie Pearson (New Holland Group) provides a world-tour of emerging global markets.

3:40 – 4:20 PM – State of the Market: What the Data Tells Us About the Coming Year
Karson Humiston (Vangst) and Frank Colombo (Viridian Capital Advisors) dissect the latest MJBiz Factbook data and its implications.


Thursday, December 4

10:00 – 10:40 AM – From Battlefield to Breakthrough: Veteran Advocacy Driving Psychedelic Reform
Jason Moore-Brown (WeedMaps) spotlights the veterans accelerating psychedelic policy change.

10:50 – 11:30 AM – Charting a Profitable Path in an Era of Balkanized Cannabis Policy
Michelle Rutter Friberg (NCIA) helps outline survival strategies for navigating fragmented state-by-state regulation.

10:50 – 11:30 AM – How Unchecked Credit and Poor Collections Are Strangling the Cannabis Supply Chain
Adam Stettner (FundCanna) and Jun S. Lee (Nabis) unpack the financial pitfalls tightening the industry’s margins.

11:40 AM – 12:20 PM – Midwest Momentum: Navigating Cannabis in Ohio & Michigan
Emilie Ramach (Beneleaves) covers the Midwest’s rapid regulatory and market evolution.

11:40 AM – 12:20 PM – The Intersection of Cannabis & Psychedelics: Synergies & Challenges
Shanetha Marable-Lewis (Veterans 22) & Scheril Murray Powell (The JUSTÜS Foundation) examine the growing overlap between the two emerging industries.

2:50 – 3:30 PM – Retail Tech & Payments: Cashless Transactions, POS Innovations & the Future of Cannabis Sales
Aubrey Amatell (PayRio) explores how payments innovation is shaping cannabis retail.

2:50 – 3:30 PM – Land of 10,000 Lakes and Legalization: Minnesota’s Cannabis Industry in Transition
Jen Reise (NorthStar Consulting) & Jason Tarasek (Vicente) break down Minnesota’s path from legalization to implementation.

3:40 – 4:20 PM – Navigating the Legal Labyrinth: Compliance, Ethics & Psychedelic Practice
Joshua Kappel (Vicente) discusses the legal frameworks emerging around psychedelics.


Friday, December 5

11:00 AM – 12:00 PM – Lounge Ready: Mastering Cannabis Hospitality
Dale Sky Jones (Oaksterdam) takes a deep dive into the future of consumption lounges and hospitality design.

11:00 AM – 12:00 PM – The New Era of Cannabis Delivery: Creating Loyalty Beyond the Transaction
Matt Krishnamachari (Purple Lotus) closes out the week providing insight into cannabis delivery trends.


If you plan to walk the Expo floor, make sure to visit National Cannabis Industry Association members below: 

Abstrax (booth #C20911)

Accounting Buds (#C25232)

Apex Trading (#C25113)

Baker Perkins (#C23707)

Bankcard International Group (#C26422)

Beaker & Wrench (#C23529)

Boveda, Inc. (#N14807)

Canna Carton (#C23629)

Gamut Packaging (#C21032)

Hanwha Vision (#C26817)

KayaPush (#C25509)

Linde Gas & Equipment Inc (#N13917)

Paragon Payroll (#C25830)

Prairie Island CBH Inc (#N15732)

PreRoll-Er (#C22018)

Proteus420 (#C25507)

Purpl Scientific Inc. (#N13819)

RollPros (#C20914)

Royal 4 Systems (#C26622)

CCELL (#C25417)

Sweed (#C27421)

Taylor (#C21536)

Urban-Gro (#N14306)

WECO (#C25511)

Across finance, compliance, retail innovation, policy, plant science, and psychedelics, our members help deliver a comprehensive look at the forces shaping cannabis in 2025. From consolidation and credit stress to Indigenous sovereignty and global expansion, attendees will walk away with a thorough understanding of where the industry is heading next.

Congressional Movement and Election Roundup

November has been a busy month in cannabis policy: Congress is on the brink of ending the longest-ever government shutdown (with implications for the hemp industry and veterans access), while Virginia and New Jersey just held statewide elections that will undoubtedly change the cannabis landscape in those states (well, Commonwealth in Virginia’s case!). Let’s take a look at some of the latest updates and what it means for the cannabis industry:

Congress

There have been two big developments from Washington, D.C. related to hemp and veterans access to medical cannabis that have taken place in the last week:

Hemp ban on the horizon

You’ve probably heard by now that this most recent government shutdown has been the longest in American history. But did you know that when the Senate voted to reopen it earlier this week that Sen. Mitch McConnell (R-KY) successfully included language in the bill that would ban all hemp-derived products with more than 0.4% THC? 

Well, that’s exactly what happened just days ago. In response to the inclusion of this language, Kentucky’s other Senator, Rand Paul (R) filed an amendment that would have struck that THC ban language from the minibus. What followed were many news stories, a flurry of lobbying, and ultimately, a vote on the Senate floor; on Monday evening, the Senate voted not to advance Sen. Paul’s amendment, leaving Sen. McConnell’s language (known colloquially as the “hemp ban”) in place. The final vote was 76-24. 

While the House has not yet voted on this particular version of the bill, almost identical THC-banning language was passed by the chamber previously. The passage of Sen. McConnell’s language in the upper chamber all but guarantees that this language will become the law of the land- but it will be one year before the ban goes into effect. 

Veterans left behind

In addition to including the aforementioned hemp ban, the Senate’s spending package also omitted a key provision related to veterans access. For context, the House had also previously passed language pertaining to VA doctors recommending marijuana to veterans, but according to Marijuana Moment, “the negotiated bill contains no language on the issue at all.” That’s surely an interesting way to honor the men and women who have served our country right at Veteran’s Day…

Virginia: a new Governor sets the stage for progress

Virginia has lived in a strange limbo since 2021: cannabis is legal- but there’s no regulated retail market. That stalemate largely stemmed from repeated vetoes from outgoing Gov. Glenn Youngkin (R), despite repeated attempts for reform made by the legislature. Now that voters have elected former-Congresswoman Abigail Spanberger (D), who campaigned on establishing a regulated adult-use market and Democrats have expanded their majority to a super majority in the House of Delegates, the prospects for a retail framework in 2026 are incredibly promising. Note that during her time in Congress, Spanberger voted for regulated adult-use cannabis via the MORE Act and was a cosponsor of the SAFE Banking Act.

Expect legislators in the Old Dominion to begin refining and reintroducing bills that lay out licensing structures, prioritize equity reinvestment, and potentially look to a phased launch for Virginia’s market. Operators should consider preparing for an accelerated early-session push focused on clear timelines for the Cannabis Control Authority, strong product safety standards, and funding for community reinvestment. 

New Jersey: homegrow on the horizon?

The Garden State also chose a new governor earlier this month: former-Congresswoman Mikie Sherrill (D). Sherrill has publicly backed legalizing home cultivation– a provision which the state has lacked. If the Sherrill administration signals support, bills like S1985 (personal grow allowances for medical and adult use) could finally move. Like her former roommate in DC, Alison Spanberger, Mikie Sherrill also cosponsored the SAFE Banking Act and voted in favor of the MORE Act. 

New Jersey already has a functioning adult-use market under the Cannabis Regulatory Commission (CRC), but allowing for home grow would be a targeted, consumer-friendly reform that eases price pressure, helps patients, and aligns New Jersey with other (and many neighboring) states.

These election outcomes and federal policy shifts underscore a critical inflection point for the cannabis and hemp industries. We cannot allow these trends to point to a future where cannabis policy becomes more polarized- we must continue to amplify our voices at the ballot box and through groups like NCIA and continue to unite around common-sense policies. Make sure your business has a seat at the table in 2026 and join the movement today! 

Join an NCIA Committee: Lead, Collaborate, and Shape the Future of Cannabis

2026 Committee Applications Now Open!  Joining a National Cannabis Industry Association (NCIA) committee is one of the best ways to get involved, expand your network, and influence national cannabis policy. Work alongside top professionals, advocates, and innovators to help move the industry forward.

Why Join?

  • Build connections with professionals from all sectors of the cannabis industry through virtual meetings, events, and cross-committee projects.
  • Share your expertise and build your professional profile as a thought leader in the industry.
  • Help shape NCIA’s advocacy efforts and provide input on national legislation and regulations.
  • Gain early access to market trends, policy updates, and NCIA briefings, plus complimentary access to Cannabis NewsHub.
  • Enhance leadership, communication, and collaboration skills while contributing to real industry impact.

Eligibility & Commitment

  • Your company must be an active NCIA member throughout your term.
  • Expect to dedicate 3–5 hours per month to meetings and projects.
  • Members can serve on one committee at a time; one seat per company per committee.

Ready to Get Involved?

Join one of NCIA’s 13 committees and make your voice heard in shaping the future of cannabis.

Apply now to collaborate, educate, and advocate with industry leaders. Not a member yet? Visit our Join Now page to explore membership options and benefits. Have questions? Reach out to Committees@thecannabisindustry.org for answers!

Join an NCIA Committee: Lead, Collaborate, and Shape the Future of Cannabis

2026 Committee Applications Now Open!  Joining a National Cannabis Industry Association (NCIA) committee is one of the best ways to get involved, expand your network, and influence national cannabis policy. Work alongside top professionals, advocates, and innovators to help move the industry forward.

Why Join?

  • Build connections with professionals from all sectors of the cannabis industry through virtual meetings, events, and cross-committee projects.
  • Share your expertise and build your professional profile as a thought leader in the industry.
  • Help shape NCIA’s advocacy efforts and provide input on national legislation and regulations.
  • Gain early access to market trends, policy updates, and NCIA briefings, plus complimentary access to Cannabis NewsHub.
  • Enhance leadership, communication, and collaboration skills while contributing to real industry impact.

Eligibility & Commitment

  • Your company must be an active NCIA member throughout your term.
  • Expect to dedicate 3–5 hours per month to meetings and projects.
  • Members can serve on one committee at a time; one seat per company per committee.

Ready to Get Involved?

Join one of NCIA’s 13 committees and make your voice heard in shaping the future of cannabis.

Apply now to collaborate, educate, and advocate with industry leaders. Not a member yet? Visit our Join Now page to explore membership options and benefits. Have questions? Reach out to Committees@thecannabisindustry.org for answers!

This site uses cookies. By using this site or closing this notice, you agree to the use of cookies and our privacy policy.